Tongue abnormality

TONGUEABNORMALITY

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K14 Hospital discharge: ICD-9 — 529 Hospital discharge: ICD-8 — 529 Cause of death: ICD-10 — K14 Cause of death: ICD-9 — 529 Cause of death: ICD-8 — 529 2 out of 7 registries used, show all original rules.	2655
4. Check minimum number of events None	2655
5. Include endpoints None	2655
6. Filter based on genotype QC (FinnGen only)	2392

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3
Parent code in ICD-10: K00-K14
Name in latin: Morbi linguae

NAME	TONGUEABNORMALITY
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K14
HD_ICD_9	529
HD_ICD_8	529
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K14
COD_ICD_9	529
COD_ICD_8	529
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Tongue abnormality based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	14364	9193	5115
Only index persons	13250	8656	4594
Unadjusted period prevalence (%)
Whole population	0.22	0.26	0.14
Only index persons	0.27	0.32	0.18
Median age at first event (years)
Whole population	57.72	59.61	54.28
Only index persons	57.54	59.29	54.24

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2392	1614	778
Unadjusted period prevalence (%)	0.50	0.57	0.36
Median age at first event (years)	59.69	59.13	60.84

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2481: Matched controls
24810

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

K14.60

ICD-10 Finland

Glossopyrosis

194.5

307.7

460

K14.1

ICD-10 Finland

Geographic tongue

136.4

307.7

420

K14.9

ICD-10 Finland

Disease of tongue, unspecified

152.0

307.7

283

K14.61

ICD-10 Finland

Glossodynia

201.1

307.7

642

K14.5

ICD-10 Finland

Plicated tongue

112.3

307.7

187

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

26.5

307.7

439

200

K14.69

ICD-10 Finland

Tongue pain UNS

156.6

307.7

350

A07AA02

ATC

nystatin; oral

6.8

257.3

455

796

A01AB09

ATC

miconazole; local oral

5.6

250.3

565

1245

K14.68

ICD-10 Finland

Other tongue pain

100.9

187.2

D20

ICPC

Mouth/tongue/lip symptom/complaint

6.1

180.0

339

623

SBA00

NOMESCO Finland

Microbiological examinations

9.0

177.6

230

280

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

6.9

148.6

242

382

K14.6

ICD-10 Finland

Glossodynia

68.9

146.5

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

5.7

139.2

279

540

K14.88

ICD-10 Finland

Other diseases of tongue

656.0

127.6

125

K14.09

ICD-10 Finland

Glossit UNS

172.8

125.7

131

SAA03

NOMESCO Finland

Extended examination of mouth

2.6

119.5

1268

7065

A01AB04

ATC

amphotericin B; local oral

4.9

117.5

277

616

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

6.4

116.4

202

339

R68.2

ICD-10 Finland

Dry mouth, unspecified

15.7

114.9

100

J02AC01

ATC

fluconazole; systemic

2.4

101.5

1273

7489

SAA04

NOMESCO Finland

Special examination of mouth

4.5

100.9

265

641

A02BC05

ATC

esomeprazole; systemic

2.4

100.0

1308

7822

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

4.7

99.1

247

573

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

10.3

96.3

109

110

N03AE01

ATC

clonazepam; systemic

4.2

96.1

281

737

WZC00

NOMESCO Finland

Treatment plan or consultation

2.3

86.6

1170

6961

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.4

86.4

930

5025

K11.70

ICD-10 Finland

Hypoptyalism

14.2

82.9

EJB10

NOMESCO Finland

Excision of tumor or other lesion of apex or body of tongue

17.5

82.7

K13.78

ICD-10 Finland

Other change in the oral mucosa

5.4

76.9

157

306

B37.0

ICD-10 Finland

Candidal stomatitis

8.8

72.5

108

K14.08

ICD-10 Finland

Another glossit

99.3

70.3

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

18.5

70.0

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

8.2

66.3

112

K12.18

ICD-10 Finland

Other forms of stomatitis

11.4

65.9

K13.29

ICD-10 Finland

Indefinite leukoplakia

8.0

64.4

113

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

64.4

924

5464

B37.08

ICD-10 Finland

Other candidal stomatitis

9.4

64.2

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

63.6

1066

6669

G50.1

ICD-10 Finland

Atypical facial pain

6.0

62.1

112

194

A02BC03

ATC

lansoprazole; oral

2.1

60.4

886

5256

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.8

58.6

329

1284

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

58.4

710

3917

A01AC01

ATC

triamcinolone; local oral

5.9

55.8

102

179

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

55.7

707

3954

N03AX16

ATC

[U] pregabalin

2.1

55.2

719

4056

N03AX12

ATC

[U] gabapentin; oral

2.2

52.1

530

2709

R07.0

ICD-10 Finland

Pain in throat

3.0

51.6

247

881

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

50.7

827

5028

SAA01

NOMESCO Finland

Simple examination of mouth

2.0

50.5

1861

14767

K14.0

ICD-10 Finland

Glossitis

132.7

49.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

48.8

1140

7769

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

48.1

855

5331

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.4

48.1

362

1623

A02BC02

ATC

pantoprazole; systemic

2.0

47.4

1850

14781

D10.19

ICD-10 Finland

Benign tumor of the tongue UNS

13.6

46.9

R13

ICD-10 Finland

Dysphagia

2.7

46.1

265

1042

SBA10

NOMESCO Finland

Measurement of salivary flow rate

6.7

45.6

112

A02BC01

ATC

omeprazole; systemic

1.9

45.1

788

4865

K30

ICD-10 Finland

Functional dyspepsia

2.3

45.0

377

1769

A01AB10

ATC

natamycin; local oral

4.1

44.9

126

318

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.5

44.8

303

1290

N06AX11

ATC

mirtazapine; oral

1.8

43.7

968

6427

UJF32

NOMESCO Finland

Coloscopy

1.9

43.5

773

4790

K14.31

ICD-10 Finland

Coated tongue

71.2

43.1

G44.2

ICD-10 Finland

Tension-type headache

2.2

42.1

433

2206

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

6.5

41.9

109

R52.9

ICD-10 Finland

Pain, unspecified

2.3

41.6

342

1588

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.3

40.5

336

1566

SAA02

NOMESCO Finland

Basic examination of mouth

1.8

40.1

1682

13336

N06AX21

ATC

duloxetine; oral

2.2

40.0

382

1887

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

40.0

328

1521

R20.2

ICD-10 Finland

Paraesthesia of skin

2.7

39.5

236

944

K14.2

ICD-10 Finland

Median rhomboid glossitis

393.5

39.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

38.8

425

2214

A02BA02

ATC

ranitidine; systemic

2.0

38.5

558

3212

M79.1

ICD-10 Finland

Myalgia

2.1

38.5

456

2445

R51.80

ICD-10 Finland

Headache

2.0

38.2

468

2540

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.6

38.0

230

925

K14.80

ICD-10 Finland

Enlargement of tongue

135.5

37.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

37.8

1224

8957

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

37.7

543

3118

H02AB06

ATC

prednisolone; systemic

1.7

37.5

1265

9351

SXA10

NOMESCO Finland

Oral mucosal sampling

5.5

37.5

136

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

36.9

1186

8638

Z01.2

ICD-10 Finland

Dental examination

1.7

36.9

1206

8824

K14.39

ICD-10 Finland

Papillary hypertrophy of the tongue UNS

192.9

36.9

M79.6

ICD-10 Finland

Pain in limb

1.7

36.6

1205

8830

K12.10

ICD-10 Finland

Stomatitis NOS

9.0

36.4

R21

ICPC

Throat symptom/complaint

1.9

35.9

542

3154

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.2

34.9

230

D07AC01

ATC

betamethasone; topical

1.7

34.8

971

6773

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.6

34.7

120

350

SBB10

NOMESCO Finland

Dental impressions

2.7

34.5

204

810

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.7

33.9

192

746

A02BC04

ATC

rabeprazole; oral

2.3

33.4

283

1326

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

33.3

377

1979

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

33.1

1282

9708

R51.81

ICD-10 Finland

Facial pain NOS

3.8

33.1

103

280

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

11.9

32.5

C05AA08

ATC

fluocortolone; rectal, topical

2.0

32.4

394

2123

N02AX02

ATC

tramadol; systemic, rectal

1.7

32.3

1119

8217

M03BX02

ATC

tizanidine; oral

1.7

32.0

1559

12476

K13.20

ICD-10 Finland

Idiopathic leukoplakia

12.0

31.7

R53

ICD-10 Finland

Malaise and fatigue

1.7

31.6

696

4521

XQ802

NOMESCO Finland

Epicutan test

3.1

31.6

138

465

K08.80

ICD-10 Finland

Toothache NOS

2.3

31.2

268

1262

R42

ICD-10 Finland

Dizziness and giddiness

1.8

31.0

661

4251

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

30.9

214

916

F45.8

ICD-10 Finland

Other somatoform disorders

2.5

30.6

198

821

XQ800

NOMESCO Finland

Prick test

2.4

30.4

218

948

N05BA04

ATC

oxazepam; oral

1.7

30.4

716

4731

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.7

30.4

178

703

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.8

30.4

621

3943

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

30.0

507

3041

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

30.0

201

848

A03FA02

ATC

cisapride; oral, rectal

2.3

29.8

234

1060

N02BF01

ATC

gabapentin; oral

2.1

29.5

325

1686

E0000UV, ,

ATC

1.6

29.4

1078

7971

R01AD09

ATC

mometasone; nasal

1.6

29.2

1139

8544

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

29.1

570

3569

SFA10

NOMESCO Finland

One-surface restoration

1.6

28.8

1360

10667

M54.2

ICD-10 Finland

Cervicalgia

2.2

28.7

252

1196

EJ2S1

NOMESCO Finland

Photography of oral mucosa

5.8

28.5

N06AX16

ATC

venlafaxine; oral

1.9

28.4

396

2230

K07.60

ICD-10 Finland

Snapping jaw

2.6

28.3

165

650

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

27.7

1357

10694

L01

ICPC

Neck symptom/complaint

1.8

27.2

464

2782

J01DB01

ATC

cefalexin; oral

1.8

27.2

2053

18000

K12.00

ICD-10 Finland

Recurrent oral aphthae

4.7

27.1

137

K59.0

ICD-10 Finland

Constipation

2.5

26.8

180

759

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

26.6

762

5268

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

26.6

297

1546

M54.5

ICD-10 Finland

Low back pain

1.6

26.4

953

6968

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

26.3

365

2049

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

26.2

628

4142

EKA10

NOMESCO Finland

iopsy of buccal mucosa

3.5

25.6

261

P01AB01

ATC

metronidazole; oral, rectal

1.6

25.5

1026

7675

WYA10

NOMESCO Finland

Emergency care or similar visit

2.3

25.3

212

985

UKC02

NOMESCO Finland

Cystoscopy

1.8

25.3

399

2331

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.0

25.1

116

404

R01AD08

ATC

fluticasone; nasal

1.6

25.0

711

4893

K13.74

ICD-10 Finland

Lichen rubs planus in the mouth

4.0

25.0

181

N06AA09

ATC

amitriptyline; systemic

2.0

24.7

287

1514

D01

ICPC

Abdominal pain/cramps general

1.9

24.3

347

1961

A01

ICPC

Pain general/multiple sites

1.9

23.8

313

1721

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

23.7

240

1203

R03AC02

ATC

salbutamol; inhalant

1.5

23.4

1367

11031

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.5

23.2

126

R07.3

ICD-10 Finland

Other chest pain

1.9

23.0

303

1667

M25.5

ICD-10 Finland

Pain in joint

1.6

22.9

851

6210

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

22.9

1068

8196

R52.2

ICD-10 Finland

Other chronic pain

2.7

22.9

129

500

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

22.8

382

2267

WX110

NOMESCO Finland

Infiltration anesthesia

1.6

22.4

1744

14909

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

22.4

1049

8048

D06

ICPC

Abdominal pain localized other

2.0

22.3

253

1321

A06AD11

ATC

lactulose; oral

1.8

22.2

395

2386

K11.2

ICD-10 Finland

Sialoadenitis

2.9

22.1

106

377

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

22.1

314

1770

H02AB04

ATC

methylprednisolone; systemic

1.8

22.1

387

2328

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

21.6

292

1618

R06.0

ICD-10 Finland

Dyspnoea

1.6

21.6

721

5121

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

21.5

451

2851

SXC03

NOMESCO Finland

Other oral or dental procedure

4.8

21.5

101

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

21.5

1080

8384

J01AA02

ATC

doxycycline; systemic

1.6

21.5

1924

16892

Z01.9

ICD-10 Finland

Special examination, unspecified

2.2

21.3

181

846

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

21.3

348

2049

N02BE01

ATC

paracetamol; systemic, rectal

1.9

21.2

2238

20500

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

21.2

109

403

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

4.3

21.1

127

J02AC02

ATC

itraconazole; systemic

1.7

21.0

456

2910

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

21.0

178

831

R06AE07

ATC

cetirizine; oral

1.5

21.0

1080

8414

N06AB04

ATC

citalopram; systemic

1.6

20.8

526

3492

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

20.6

115

443

K02.1

ICD-10 Finland

Caries of dentine

1.5

20.6

1385

11373

M01AC06

ATC

meloxicam; systemic, rectal

1.5

20.5

916

6917

KMAK, ,

NOMESCO Finland

1.5

20.5

1186

9448

R12

ICD-10 Finland

Heartburn

2.0

20.4

235

1233

H93.1

ICD-10 Finland

Tinnitus

2.1

20.3

200

991

N06AB10

ATC

escitalopram; oral

1.7

20.3

485

3172

SPAT1263

SPAT

Sampling

1.5

20.3

1016

7855

R01AD12

ATC

fluticasone furoate; nasal

1.5

20.1

748

5426

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

20.0

229

1198

A06AC51

ATC

ispaghula, combinations; oral

2.4

20.0

143

620

K13.22

ICD-10 Finland

Erythroplakia of oral epithelium, including tongue

17.4

20.0

L03

ICPC

Low back symptom/complaint

1.5

20.0

757

5514

K14

ICD-10 Finland

Diseases of tongue

23.6

19.9

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

19.9

384

2369

D07AD01

ATC

clobetasol; topical

1.7

19.9

435

2778

L43.8

ICD-10 Finland

Other lichen planus

3.5

19.6

204

K14.38

ICD-10 Finland

Other papillary hypertrophy of the tongue

201.5

19.6

K14.30

ICD-10 Finland

Black hairy tongue

40.4

19.5

A03CA02

ATC

clidinium and psycholeptics; oral

2.2

19.5

166

776

SXC05

NOMESCO Finland

Other oral or dental procedure

2.2

19.5

175

836

T78.4

ICD-10 Finland

Allergy, unspecified

2.5

19.3

127

530

M01AB05

ATC

diclofenac; systemic, rectal

1.5

19.3

1586

13474

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.2

19.2

237

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

19.2

664

4734

J01MA02

ATC

ciprofloxacin; systemic

1.5

19.1

935

7167

M01AH05

ATC

etoricoxib; oral

1.5

19.1

1518

12795

R05

ICD-10 Finland

Cough

1.6

19.1

553

3784

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

19.1

475

3133

A04

ICPC

Weakness/tiredness general

1.7

19.0

419

2680

SFA20

NOMESCO Finland

Two-surface restoration

1.5

18.9

1379

11419

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.5

18.9

866

6547

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.2

18.9

170

813

J01FA10

ATC

azithromycin; systemic

1.5

18.8

1349

11130

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

18.8

504

3383

52999

ICD-8 Finland

Diseases of the tongue and other oral conditions, Other and unspecified

+∞

18.8

S01.50

ICD-10 Finland

Open wound in oral cavity

4.6

18.7

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

18.7

929

7137

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

21.0

18.6

S29

ICPC

Skin symptom/complaint other

1.6

18.6

540

3695

K14.42

ICD-10 Finland

Atrophic glossitis UNS

191.4

18.6

K14.81

ICD-10 Finland

Crenated tongue

191.4

18.6

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

18.5

155

720

AA1AD

NOMESCO Finland

CT of head and brain

1.5

18.4

748

5510

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

18.4

400

2547

N05CF02

ATC

zolpidem; oral

1.6

18.3

444

2907

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

18.2

564

3914

H57.1

ICD-10 Finland

Ocular pain

2.5

18.2

117

484

R00.2

ICD-10 Finland

Palpitations

1.9

18.1

224

1203

B37.01

ICD-10 Finland

Acute athrophy candidal stomatitis

14.4

18.1

J05AB01

ATC

aciclovir; systemic

1.6

18.0

564

3922

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

18.0

211

1113

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

18.0

245

1360

R30.0

ICD-10 Finland

Dysuria

2.4

17.8

130

570

N05BA12

ATC

alprazolam; oral

1.8

17.6

267

1532

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.3

17.6

106

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

17.5

222

1202

K14.8

ICD-10 Finland

Other diseases of tongue

181.2

17.5

P01BA02

ATC

hydroxychloroquine; oral

1.9

17.5

228

1246

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

17.5

299

1778

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

5.9

17.4

K13.1

ICD-10 Finland

Cheek and lip biting

5.6

17.4

N05CF01

ATC

zopiclone; oral

1.5

17.4

797

6002

R06AX27

ATC

desloratadine; oral

1.5

17.4

676

4923

C07AB07

ATC

bisoprolol; oral

1.4

17.4

1208

9848

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

17.4

225

1227

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

17.3

457

3052

L08

ICPC

Shoulder symptom/complaint

1.5

17.3

595

4222

J01FA09

ATC

clarithromycin; systemic

1.5

17.2

740

5503

S18

ICPC

Laceration/cut

1.4

17.0

1174

9544

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.3

17.0

130

581

D02

ICPC

Abdominal pain epigastric

2.1

16.9

176

889

N05CD07

ATC

temazepam; oral

1.8

16.9

299

1795

A02BA04

ATC

nizatidine; systemic

2.0

16.9

201

1065

JDB10

NOMESCO Finland

Percutaneous gastrostomy

4.2

16.7

106

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

16.7

531

3698

M01AE02

ATC

naproxen; oral, rectal

1.4

16.7

1333

11116

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

16.7

394

B37.02

ICD-10 Finland

Chronic hyperplastic candidal stomatitis

35.3

16.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

16.7

247

1407

SDA03

NOMESCO Finland

Periodontal treatment

1.4

16.6

950

7451

J01CA04

ATC

amoxicillin; systemic

1.5

16.6

1956

17559

J01FF01

ATC

clindamycin; systemic

1.5

16.6

646

4701

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

16.5

194

1023

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

16.4

403

2641

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

16.4

715

5323

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

4.0

16.3

117

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

16.3

739

5541

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.5

16.3

660

4839

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

16.2

313

1925

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

16.2

286

1715

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

16.2

164

821

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.5

16.1

672

4954

N05AH04

ATC

quetiapine; oral

1.6

15.9

410

2716

L04

ICPC

Chest symptom/complaint

2.0

15.9

181

944

-1, ,

NOMESCO Finland

1.5

15.9

742

5590

J01DA01

ATC

[U] cefalexin

1.4

15.9

1450

12336

R01AD11

ATC

triamcinolone; nasal

1.9

15.8

218

1213

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

2.0

15.8

172

883

D82

ICPC

Teeth/gum disease

1.4

15.8

848

6558

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

15.8

405

N06AB06

ATC

sertraline; oral

1.8

15.7

277

1660

L43.9

ICD-10 Finland

Lichen planus, unspecified

3.0

15.7

234

H02AB07

ATC

prednisone; oral

1.7

15.7

342

2172

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.1

15.7

155

768

EB1VA, ,

NOMESCO Finland

1.6

15.6

432

2909

M02AA07

ATC

piroxicam; topical

1.4

15.6

875

6818

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.0

15.6

166

846

SPAT1260

SPAT

Consultation of another employee

1.6

15.6

426

2862

TEA00

NOMESCO Finland

Biopsy of lip

4.2

15.6

SPAT1301

SPAT

No procedures

1.5

15.5

744

5627

F45.0

ICD-10 Finland

Somatization disorder

6.5

15.4

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

3.2

15.4

195

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.8

15.4

270

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

15.3

558

3995

R11

ICD-10 Finland

Nausea and vomiting

1.8

15.3

241

1398

C07AA05

ATC

propranolol; systemic

1.5

15.3

484

3362

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

15.2

336

2140

SFA30

NOMESCO Finland

Three-surface restoration

1.4

15.2

999

7997

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

15.1

547

3908

R01AD58

ATC

fluticasone, combinations; nasal

1.5

15.1

565

4067

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

15.0

208

1160

E000001, ,

ATC

1.6

14.9

451

3097

N41.1

ICD-10 Finland

Chronic prostatitis

3.2

14.9

183

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.5

14.9

551

3953

ECA20

NOMESCO Finland

Biopsy of gingiva

3.8

14.9

116

R03DC03

ATC

montelukast; oral

1.6

14.8

405

2720

L17

ICPC

Foot/toe symptom/complaint

1.4

14.8

766

5871

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

25.2

14.7

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

14.5

863

6773

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

14.5

203

1136

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

14.4

595

4360

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

14.4

322

2056

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

14.4

704

5330

C01CA24

ATC

epinephrine; parenteral

2.0

14.3

158

815

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

14.3

337

2180

L05

ICPC

Flank/axilla symptom/complaint

1.9

14.3

178

958

J01FA06

ATC

roxithromycin; oral

1.4

14.3

940

7506

L02

ICPC

Back symptom/complaint

1.7

14.3

261

1580

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

14.2

111

502

K13.28

ICD-10 Finland

Other leukoplakia or disorder of epithelium of the palate or tongue

6.4

14.1

U02

ICPC

Urinary frequency/urgency

1.6

14.1

404

2739

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.7

13.9

262

1598

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

13.9

446

3101

G04CA02

ATC

tamsulosin; oral

1.5

13.9

429

2958

M54.3

ICD-10 Finland

Sciatica

2.0

13.9

158

825

D07AC13

ATC

mometasone; topical

1.4

13.8

668

5040

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.8

13.7

247

R02

ICPC

Shortness of breath/dyspnoea

1.6

13.7

345

2268

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.8

13.7

218

1269

52998

ICD-8 Finland

Diseases of the tongue and other oral conditions, Alii definiti

+∞

13.6

M01AH02

ATC

rofecoxib; oral

1.6

13.5

314

2025

J01EA01

ATC

trimethoprim; systemic

1.4

13.5

645

4855

EJ1S1

NOMESCO Finland

Photography of tongue

10.1

13.5

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

13.4

408

2800

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

13.4

596

4423

R03BA05

ATC

fluticasone; inhalant

1.5

13.4

421

2912

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

13.4

259

1592

K60.1

ICD-10 Finland

Chronic anal fissure

2.8

13.3

240

L13

ICPC

Hip symptom/complaint

1.5

13.3

514

3711

D12

ICPC

Constipation

2.2

13.3

108

496

R60.0

ICD-10 Finland

Localized oedema

1.6

13.3

331

2171

L12

ICPC

Hand/finger symptom/complaint

1.5

13.2

419

2902

N01

ICPC

Headache

1.7

13.2

259

1597

EJB20

NOMESCO Finland

Excision of tumor or other lesion of base of tongue

40.3

13.2

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

13.1

189

1066

H92.0

ICD-10 Finland

Otalgia

1.9

13.1

158

841

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.2

13.1

112

525

E000006, ,

ATC

1.9

13.1

171

935

SPAT1254

SPAT

Administration of medicine

1.6

13.0

349

2327

D83

ICPC

Mouth/tongue/lip disease

3.7

13.0

113

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

13.0

409

2827

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.5

13.0

534

3900

SCA01

NOMESCO Finland

Preventive oral health care, short

1.4

13.0

628

4732

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

12.9

302

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

12.9

149

782

GBB00

NOMESCO Finland

Tracheostomy

3.8

12.9

100

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

12.9

184

R05

ICPC

Cough

1.4

12.9

605

4534

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

12.8

1229

10375

Z71.8

ICD-10 Finland

Other specified counselling

1.4

12.8

799

6293

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.0

12.8

135

686

F34.1

ICD-10 Finland

Dysthymia

2.3

12.8

414

A07EA06

ATC

budesonide; oral, local oral

2.3

12.7

428

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

12.6

231

1398

N02BF02

ATC

pregabalin; oral

1.8

12.6

179

1005

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

12.6

208

1223

M01AX17

ATC

nimesulide; oral

1.4

12.6

581

4338

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

12.5

306

1995

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

12.5

289

M01AH01

ATC

celecoxib; oral

1.5

12.5

439

3106

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

12.5

431

3038

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.4

12.4

381

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

12.4

1197

10095

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

12.4

461

3298

D11

ICPC

Diarrhoea

1.6

12.4

278

1776

N06AB03

ATC

fluoxetine; oral

1.6

12.4

296

1921

N06AX12

ATC

bupropion; oral

1.9

12.3

147

780

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

12.2

217

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

12.2

170

948

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.2

12.2

454

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.5

12.2

292

SPAT1312

SPAT

General health counselling

1.4

12.2

708

5497

D19

ICPC

Teeth/gum symptom/complaint

1.4

12.2

702

5443

Z00.0

ICD-10 Finland

General medical examination

1.5

12.2

457

3273

M48.0

ICD-10 Finland

Spinal stenosis

1.6

12.2

318

2107

XKD00

NOMESCO Finland

Uroflowmetry

1.6

12.2

295

1920

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.2

444

3164

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

12.1

348

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

12.1

686

5305

ZXC10

NOMESCO Finland

Use of laser

2.7

12.1

230

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

12.1

814

6482

G04CA01

ATC

alfuzosin; oral

1.7

12.0

230

1408

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

12.0

730

5710

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

12.0

1040

8611

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

12.0

176

998

K03.00

ICD-10 Finland

Approximal wear

1.8

12.0

186

1073

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

12.0

181

1036

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

3.5

12.0

115

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.6

11.9

272

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

11.9

190

1106

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.8

11.9

186

1076

SFA00

NOMESCO Finland

Small restoration

1.6

11.9

337

2275

R03BA01

ATC

beclometasone; inhalant

1.6

11.8

327

2194

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

11.8

101

474

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.0

11.7

127

652

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

11.7

1523

13396

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

11.7

266

1704

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

11.6

575

4336

EJB40

NOMESCO Finland

Hemiglossectomy

19.0

11.6

ELB10

NOMESCO Finland

Excision of minor salivary gland

11.1

11.5

D06BX01

ATC

metronidazole; topical

1.6

11.5

265

1703

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

11.5

261

1671

N06AA12

ATC

doxepin; systemic

1.9

11.5

135

713

N17

ICPC

Vertigo/dizziness

1.5

11.4

334

2268

SPAT1058

SPAT

PEF monitoring instruction

1.7

11.4

196

1165

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

11.4

164

925

D03

ICPC

Heartburn

2.1

11.3

105

509

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.8

11.3

181

1054

C05AA01

ATC

hydrocortisone; rectal, topical

1.9

11.3

133

703

N05BE01

ATC

buspirone; oral

2.4

11.3

304

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

11.3

281

1840

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.2

947

7788

G01AA10

ATC

clindamycin; vaginal

1.5

11.2

331

2253

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.2

11.2

425

M79.7

ICD-10 Finland

Fibromyalgia

2.2

11.2

419

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

3.1

11.1

146

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

11.1

203

1228

EMAK, ,

NOMESCO Finland

2.2

11.1

414

J01DA09

ATC

[U] cefadroxil

1.4

11.1

585

4460

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.7

11.0

224

1396

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.8

11.0

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

10.9

603

4632

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

10.9

325

2217

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

10.9

338

2326

XF402

NOMESCO Finland

ECG with work load test

1.6

10.8

247

1582

EMB10

NOMESCO Finland

Tonsillectomy

2.1

10.8

100

484

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

10.8

160

910

R35

ICD-10 Finland

Polyuria

1.8

10.8

162

925

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.5

10.8

354

2463

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

10.8

108

539

M05BA07

ATC

risedronic acid; oral

2.2

10.8

412

H53.1

ICD-10 Finland

Subjective visual disturbances

1.8

10.8

174

1016

N64.4

ICD-10 Finland

Mastodynia

2.3

10.8

380

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.2

10.7

439

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

10.7

315

2140

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.6

10.7

267

1747

U01

ICPC

Dysuria/painful urination

1.7

10.7

210

1294

R55

ICD-10 Finland

Syncope and collapse

1.6

10.7

257

1667

R04.2

ICD-10 Finland

Haemoptysis

2.2

10.7

394

UDC00

NOMESCO Finland

Ear microscopy

1.8

10.7

169

981

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

10.7

224

1405

Z50.5

ICD-10 Finland

Speech therapy

3.3

10.7

119

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

10.7

619

4791

C10AC01

ATC

colestyramine; oral

2.4

10.6

319

P03

ICPC

Feeling depressed

1.7

10.6

204

1251

P01

ICPC

Feeling anxious/nervous/tense

1.6

10.6

243

1559

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

8.0

10.6

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

10.6

383

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.5

10.6

105

J01DC02

ATC

cefuroxime; systemic

1.9

10.6

122

641

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

10.5

911

7501

X15

ICPC

Vaginal symptom/complaint other

2.2

10.5

423

M75.8

ICD-10 Finland

Other shoulder lesions

2.1

10.5

100

490

R50.9

ICD-10 Finland

Fever, unspecified

1.5

10.5

335

2319

C02.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of tongue

+∞

10.4

5298X

ICD-9 Finland

Diseases and other conditions of the tongue, Other specified conditions of the tongue

+∞

10.4

A03

ICPC

Fever

1.5

10.4

359

2526

SPAT1097

SPAT

Recording of ECG

1.5

10.3

340

2366

K03.0

ICD-10 Finland

Excessive attrition of teeth

2.3

10.3

323

S01

ICPC

Pain/tenderness of skin

1.9

10.3

120

632

K02.0

ICD-10 Finland

Caries limited to enamel

1.5

10.3

414

2999

J01AA04

ATC

lymecycline; systemic

1.6

10.3

272

1805

J01MA01

ATC

ofloxacin; systemic

1.7

10.3

186

1122

Z01.7

ICD-10 Finland

Laboratory examination

1.5

10.3

397

2854

D10.12

ICD-10 Finland

Bone tumor of the tip of the tongue

10.6

10.3

F01

ICPC

Eye pain

2.3

10.3

343

H03AA01

ATC

levothyroxine sodium; systemic

1.4

10.2

574

4412

L04AA06

ATC

mycophenolic acid; systemic

2.8

10.2

181

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

10.2

145

815

R39.1

ICD-10 Finland

Other difficulties with micturition

2.3

10.2

331

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

10.2

877

7207

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.9

10.2

127

685

C10AA07

ATC

rosuvastatin; oral

1.3

10.2

804

6524

M02AA10

ATC

ketoprofen; topical

1.5

10.2

374

2663

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

10.1

307

R49.08

ICD-10 Finland

Other specified dysphonia

2.5

10.1

258

R05FB02

ATC

cough suppressants and expectorants; systemic

1.3

10.1

860

7055

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.1

447

3298

J01CA08

ATC

pivmecillinam; oral

1.3

10.1

1005

8433

U07

ICPC

Urine symptom/complaint other

1.6

10.0

217

1372

N05BA01

ATC

diazepam; systemic, rectal

1.5

10.0

304

2080

D10.10

ICD-10 Finland

Benign tumor at the base of the tongue

14.6

10.0

A11

ICPC

Chest pain NOS

1.6

10.0

214

1350

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

10.0

195

1201

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.0

594

4609

N04BC05

ATC

pramipexole; oral

1.7

10.0

187

1139

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.9

10.0

156

A02BX02

ATC

sucralfate; oral

2.1

10.0

466

N03AF01

ATC

carbamazepine; oral, rectal

1.9

10.0

120

640

N06AA10

ATC

nortriptyline; systemic

2.5

10.0

242

N07CA01

ATC

betahistine; oral

1.7

9.9

178

1071

R03BA08

ATC

ciclesonide; inhalant

1.7

9.9

206

1289

S21

ICPC

Skin texture symptom/complaint

1.5

9.9

365

2598

N03AX09

ATC

lamotrigine; oral

2.0

9.9

103

522

EBB10

NOMESCO Finland

Insertion of dental implant

3.2

9.9

125

M54.8

ICD-10 Finland

Other dorsalgia

1.9

9.8

115

607

L57.0

ICD-10 Finland

Actinic keratosis

1.6

9.8

264

1758

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.4

9.8

268

UJH02

NOMESCO Finland

Anoscopy

2.0

9.8

101

510

WX290

NOMESCO Finland

Other blockage of nerve

1.3

9.8

1008

8483

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

10.7

9.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.2

9.7

390

G03CA04

ATC

estriol; systemic, vaginal

1.7

9.7

187

1147

N06AX03

ATC

mianserin; oral

1.9

9.7

117

624

N76.0

ICD-10 Finland

Acute vaginitis

1.8

9.7

133

740

J45

ICD-10 Finland

Asthma

1.6

9.7

242

1585

G04CB01

ATC

finasteride; oral

1.7

9.7

180

1095

N06AX26

ATC

vortioxetine; oral

1.7

9.6

161

950

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

4.2

9.6

J35.0

ICD-10 Finland

Chronic tonsillitis

2.0

9.6

479

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

9.6

351

2495

N02AA05

ATC

oxycodone; systemic

1.4

9.6

438

3246

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

9.6

194

1206

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

9.6

439

3255

P76

ICPC

Depressive disorder

1.8

9.5

144

825

D07AA02

ATC

hydrocortisone; topical

1.5

9.5

294

2018

S08

ICPC

Skin colour change

1.8

9.5

142

811

R74

ICPC

Upper respiratory infection acute

1.3

9.5

684

5462

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

2.1

9.5

414

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

9.4

227

1473

EHA10

NOMESCO Finland

Biopsy of palate

4.1

9.4

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

4.1

9.4

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.1

9.4

389

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

3.1

9.4

129

M01AX05

ATC

glucosamine; oral

1.4

9.4

482

3645

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

9.4

282

1925

SCA02

NOMESCO Finland

Preventive oral health care

1.6

9.3

215

1381

T78.3

ICD-10 Finland

Angioneurotic oedema

3.0

9.3

135

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

2.6

9.3

214

N05AA02

ATC

levomepromazine; systemic

2.1

9.3

424

D18.0

ICD-10 Finland

Haemangioma, any site

2.3

9.3

281

R01AD59

ATC

mometasone, combinations; nasal

1.8

9.3

143

824

K03.66

ICD-10 Finland

Tooth plaque

1.7

9.3

181

1115

IHZ05, ,

SPAT

2.1

9.3

398

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.1

9.2

SPAT1325

SPAT

Vaccination

1.3

9.2

748

6074

UJF92

NOMESCO Finland

Capsular endoscopy

2.5

9.2

215

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.2

704

5669

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

9.1

503

3846

EB1WA, ,

NOMESCO Finland

4.3

9.1

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.0

9.1

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.9

9.1

108

574

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

9.1

255

1715

A29

ICPC

General symptom/complaint other

1.5

9.1

321

2266

C02.10

ICD-10 Finland

Malignant neoplasm of tip of tongue

15.6

9.0

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

9.0

245

1635

H01

ICPC

Ear pain/earache

1.5

9.0

263

1783

R51

ICD-10 Finland

Headache

1.9

9.0

121

669

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

9.0

141

817

C10AA01

ATC

simvastatin; oral

1.3

9.0

959

8083

SPAT1153

SPAT

Removal of sutures

1.3

9.0

722

5851

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

9.0

462

3493

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.9

9.0

104

548

L10

ICPC

Elbow symptom/complaint

1.9

9.0

116

634

S02

ICPC

Pruritus

2.0

8.9

458

K11.72

ICD-10 Finland

Xerostomia

18.7

8.9

R96

ICPC

Asthma

1.6

8.9

242

1615

L50.3

ICD-10 Finland

Dermatographic urticaria

2.7

8.9

172

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

8.9

215

1397

R09

ICPC

Sinus symptom/complaint

1.6

8.8

186

1168

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

8.8

268

1832

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

8.8

344

2473

EB1AD

NOMESCO Finland

Cone beam CT of teeth and jaws (one quarter)

4.9

8.8

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.3

8.8

269

P29

ICPC

Psychological sympt/compl other

1.7

8.8

151

898

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

8.8

361

2621

R06AE09

ATC

levocetirizine; oral

1.5

8.8

303

2127

D01BA02

ATC

terbinafine; oral

1.4

8.8

557

4354

X58

ICD-10 Finland

Exposure to other specified factors

1.5

8.8

316

2237

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.7

8.7

168

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

8.7

589

4649

J31.2

ICD-10 Finland

Chronic pharyngitis

4.1

8.7

B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.8

8.7

146

XA402

NOMESCO Finland

ENMG

2.4

8.7

246

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

8.7

409

3044

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

8.7

140

819

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.6

8.7

198

J30.3

ICD-10 Finland

Other allergic rhinitis

2.1

8.6

409

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

2.1

8.6

369

R49.03

ICD-10 Finland

Atrophic dysphonia

3.0

8.6

125

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

8.6

285

1984

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.0

8.6

437

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.1

8.6

383

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.1

8.6

410

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

8.6

229

L60.0

ICD-10 Finland

Ingrowing nail

1.8

8.6

118

658

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.3

8.6

279

H13

ICPC

Plugged feeling ear

1.4

8.5

450

3413

R01AD01

ATC

beclometasone; nasal

1.4

8.5

340

2454

A05

ICPC

Feeling ill

1.8

8.5

131

755

N77.1

ICD-10 Finland

Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere

3.5

8.5

L28

ICPC

Limited function/disability (L)

1.4

8.5

461

3512

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.6

8.5

221

1460

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

8.5

2117

19946

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

8.5

606

4819

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.8

8.5

148

L04AX03

ATC

methotrexate; systemic

1.6

8.5

223

1477

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

8.5

133

771

H29

ICPC

Ear symptom/complaint other

1.5

8.5

293

2057

G47.3

ICD-10 Finland

Sleep apnoea

1.4

8.5

489

3763

SAE01, ,

NOMESCO Finland

2.7

8.5

165

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.4

8.5

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

8.5

259

1774

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

3.7

8.4

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

8.4

671

5421

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.9

8.4

132

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.3

8.4

281

UJC02

NOMESCO Finland

Rigid oesophagoscopy

3.9

8.4

K14.3

ICD-10 Finland

Hypertrophy of tongue papillae

90.4

8.4

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

8.4

198

1279

P06

ICPC

Sleep disturbance

1.5

8.3

279

1946

K14.49

ICD-10 Finland

Atrophy of the tongue papules UNS

+∞

8.3

52900

ICD-8 Finland

Diseases of the tongue and other oral conditions, Glossitis

+∞

8.3

UDM02

NOMESCO Finland

Sinoscopy

2.4

8.3

226

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

8.3

242

1639

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

8.3

110

606

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.3

790

6541

N06AX05

ATC

trazodone; oral

2.3

8.3

258

C08CA05

ATC

nifedipine; systemic

1.7

8.2

132

772

TAB00

NOMESCO Finland

Lumbar puncture

1.9

8.1

101

545

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

8.1

101

545

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.4

8.1

241

WZC00, ,

SPAT

1.4

8.1

332

2407

C10AA05

ATC

atorvastatin; oral

1.3

8.1

988

8439

H02

ICPC

Hearing complaint

1.4

8.1

353

2589

G04BD08

ATC

solifenacin; oral

1.7

8.1

158

974

WX002

NOMESCO Finland

Sedation and analgesia

1.4

8.0

437

3329

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

8.0

313

SGA01

NOMESCO Finland

Emergency treatment

1.4

8.0

326

2361

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.9

8.0

125

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.7

8.0

157

969

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

8.0

1041

8965

N05AH03

ATC

olanzapine; systemic

1.7

8.0

133

786

K29.7

ICD-10 Finland

Gastritis, unspecified

2.0

8.0

436

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

7.9

210

1393

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.9

7.9

507

L04AX01

ATC

azathioprine; systemic

1.9

7.9

500

R03AC13

ATC

formoterol; inhalant

1.8

7.9

119

682

G01AF05

ATC

econazole; vaginal

1.6

7.9

169

1066

XG410

NOMESCO Finland

Flow-volume spirometry

1.9

7.9

472

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

7.9

297

2120

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

6.6

7.9

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

13.1

7.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

7.9

115

654

R4110, ,

SPAT

1.4

7.8

328

2389

F61.0

ICD-10 Finland

Mixed personality disorders

3.0

7.8

116

A03BA03

ATC

hyoscyamine; oral

3.4

7.8

SJB00

NOMESCO Finland

Fitting of removable appliance incl. patient instructions

3.3

7.8

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

7.8

214

1432

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

7.7

331

R60.9

ICD-10 Finland

Oedema, unspecified

1.7

7.7

135

808

JN4AD

NOMESCO Finland

Body CT examination

1.5

7.7

263

1841

A07EC02

ATC

mesalazine; oral, rectal

1.8

7.7

113

643

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

2.5

7.7

192

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

3.2

7.7

L73.8

ICD-10 Finland

Other specified follicular disorders

3.3

7.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

7.6

242

1670

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.6

7.6

157

J01MA06

ATC

norfloxacin; oral

1.4

7.6

299

2151

-, ,

ICD-10 Finland

2.3

7.6

242

S06.0

ICD-10 Finland

Concussion

1.5

7.6

236

1621

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

7.6

152

943

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

7.6

155

967

N76.3

ICD-10 Finland

Subacute and chronic vulvitis

3.1

7.6

102

L29.2

ICD-10 Finland

Pruritus vulvae

2.5

7.6

187

G01AF02

ATC

clotrimazole; vaginal

2.0

7.6

409

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

11.9

7.6

G04BD07

ATC

tolterodine; oral

1.8

7.6

120

699

D06BB04

ATC

podophyllotoxin; topical

1.9

7.5

473

G04BD12

ATC

mirabegron; oral

1.4

7.5

294

2113

K04.1

ICD-10 Finland

Necrosis of pulp

1.5

7.5

226

1543

UJG02

NOMESCO Finland

Proctoscopy

2.3

7.5

238

EBB15

NOMESCO Finland

Insertion of dental implant abutment

3.7

7.5

S01GX01

ATC

cromoglicic acid; ophthalmic

1.4

7.4

435

3350

J05AB11

ATC

valaciclovir; oral

1.4

7.4

332

2446

SPAT1216

SPAT

Assessment of functional ability

1.4

7.4

359

2681

M01AB01

ATC

indometacin; systemic, rectal

1.6

7.4

157

989

R03BA02

ATC

budesonide; inhalant

1.4

7.4

391

2963

R06.4

ICD-10 Finland

Hyperventilation

2.8

7.4

131

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

7.4

399

L50.9

ICD-10 Finland

Urticaria, unspecified

1.9

7.4

434

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.4

552

4411

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.8

7.4

112

645

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

7.3

156

983

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.3

758

6324

AN1

Coronary angiography

1.5

7.3

229

1576

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

7.3

544

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

7.3

515

F29

ICPC

Eye symptom/complaint other

1.5

7.2

241

1679

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

7.2

161

1026

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

3.2

7.2

K64.1

ICD-10 Finland

Second degree haemorrhoids

2.2

7.2

254

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

7.2

523

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

7.2

523

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.3

7.2

235

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

6.2

7.2

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

7.2

322

2371

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.2

7.2

274

N05BA06

ATC

lorazepam; systemic, sublingual

1.7

7.2

118

695

N30

ICD-10 Finland

Cystitis

1.5

7.2

191

1270

N39.3

ICD-10 Finland

Stress incontinence

1.6

7.2

188

1246

H25.8

ICD-10 Finland

Other senile cataract

1.5

7.1

258

1827

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.1

7.1

315

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.1

7.1

C02.2

ICD-10 Finland

Malignant neoplasm: Ventral surface of tongue

20.1

7.1

K07.24

ICD-10 Finland

Open bite

3.5

7.1

Z50.1

ICD-10 Finland

Other physical therapy

1.7

7.1

120

712

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

7.1

370

R07.2

ICD-10 Finland

Precordial pain

2.2

7.1

250

K11.9

ICD-10 Finland

Disease of salivary gland, unspecified

4.1

7.1

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

7.1

243

1704

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

7.1

498

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

7.1

142

883

B82

ICPC

Anaemia other/unspecified

2.0

7.1

371

R06AX13

ATC

loratadine; oral

1.4

7.1

305

2233

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

7.1

105

601

IGY02, ,

SPAT

2.7

7.0

129

K03.80

ICD-10 Finland

Irradiated enamel

1.7

7.0

124

745

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.5

7.0

176

UJC01

NOMESCO Finland

Scopy of lower throat

3.1

7.0

A98

ICPC

Health maint/preventive medicine

1.7

7.0

2355

22796

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.9

7.0

428

UJD02

NOMESCO Finland

Gastroscopy

1.8

7.0

106

610

7325

FHL

Bladder stretching

7.0

EP1AE, ,

SPAT

2.3

7.0

226

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.0

191

1278

N63

ICD-10 Finland

Unspecified lump in breast

1.6

7.0

151

957

A02BA03

ATC

famotidine; systemic

1.9

7.0

436

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

6.9

245

1727

SPAT1240

SPAT

Therapeutic discussion

1.5

6.9

200

1353

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

6.9

418

3233

L29

ICPC

Musculoskeletal sympt/complt other

1.5

6.9

208

1420

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

7.5

6.9

M01AH03

ATC

valdecoxib; oral

1.7

6.9

131

803

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.5

6.9

256

1823

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.7

6.9

125

L50.8

ICD-10 Finland

Other urticaria

2.4

6.9

184

K80

ICPC

Cardiac arrhythmia NOS

1.5

6.9

202

1373

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.8

6.8

106

614

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

6.8

170

1113

S04

ICPC

Lump/swelling localized

1.5

6.8

245

1734

L15

ICPC

Knee symptom/complaint

1.3

6.8

592

4822

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.8

393

3019

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

6.8

151

963

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

6.8

107

623

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

2.3

6.8

210

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.5

6.8

191

1287

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

2.3

6.8

223

EJC00

NOMESCO Finland

Suture of tongue or floor of mouth

16.7

6.7

J01MA12

ATC

levofloxacin; systemic

1.4

6.7

392

3015

K13.2

ICD-10 Finland

Leukoplakia and other disturbances of oral epithelium, including tongue

7.2

6.7

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

6.7

125

763

J01AA07

ATC

tetracycline; systemic

1.4

6.7

290

2124

C10AA03

ATC

pravastatin; oral

1.6

6.7

163

1063

R43.2

ICD-10 Finland

Parageusia

22.6

6.7

M01AB55

ATC

diclofenac, combinations; oral

1.6

6.6

155

1000

XLA10, ,

NOMESCO Finland

1.7

6.6

107

627

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

6.6

150

962

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

6.6

118

712

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.6

6.6

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.9

6.6

409

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

6.6

526

4235

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.0

6.6

367

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

6.6

312

A28

ICPC

Limited function/disability NOS

1.3

6.5

422

3295

I95.1

ICD-10 Finland

Orthostatic hypotension

1.8

6.5

511

M03BX01

ATC

baclofen; systemic

2.3

6.5

201

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.5

6.5

152

N05AX12

ATC

aripiprazole; systemic

1.9

6.5

375

ELA30

NOMESCO Finland

Biopsy of salivary gland

6.9

6.5

SPAT1053

SPAT

Memory test

1.4

6.5

307

2282

N06AX22

ATC

agomelatine; oral

2.2

6.5

227

C03CA01

ATC

furosemide; systemic

1.3

6.5

675

5621

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

6.5

557

K05.1

ICD-10 Finland

Chronic gingivitis

1.6

6.5

140

888

B34.9

ICD-10 Finland

Viral infection, unspecified

2.1

6.4

267

R06AX22

ATC

ebastine; oral

1.4

6.4

364

2786

K13.6

ICD-10 Finland

Irritative hyperplasia of oral mucosa

2.8

6.4

107

5951A

ICD-9 Finland

Cystitis, Chronic interstitial cystitis

7.4

6.4

C07AB02

ATC

metoprolol; systemic

1.3

6.4

429

3369

H15.1

ICD-10 Finland

Episcleritis

2.6

6.4

136

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

6.4

217

1520

F32.1

ICD-10 Finland

Moderate depressive episode

1.7

6.4

113

681

J01MA14

ATC

moxifloxacin; systemic

1.5

6.3

187

1272

R08

ICPC

Nose symptom/complaint other

1.9

6.3

429

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

3.6

6.3

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.6

6.3

131

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

6.3

125

776

A02BX05

ATC

bismuth subcitrate; oral

2.5

6.3

143

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

3.3

6.3

R04.0

ICD-10 Finland

Epistaxis

1.5

6.3

165

1095

5299X

ICD-9 Finland

Diseases and other conditions of the tongue, Unspecified condition of the tongue

+∞

6.3

B02AA02

ATC

tranexamic acid; systemic

1.4

6.2

308

2306

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

2.2

6.2

231

K10.26

ICD-10 Finland

Periostitis of jaw (acute)(chronic)(suppurative)

26.7

6.2

J01FA01

ATC

erythromycin; systemic

1.4

6.2

264

1926

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.2

470

3752

K05.18

ICD-10 Finland

Chronic gingivitis

1.6

6.2

156

1025

D04

ICPC

Rectal/anal pain

2.4

6.2

162

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.5

6.2

156

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.5

6.2

206

1437

D01AE16

ATC

amorolfine; topical

1.4

6.2

253

1835

LEF40

NOMESCO Finland

Vaginal repair of enterocele

3.5

6.2

XF405

NOMESCO Finland

Symptom ECG

3.5

6.2

Z96.5

ICD-10 Finland

Presence of tooth-root and mandibular implants

6.3

6.2

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.4

6.2

261

1904

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

6.2

506

R20.0

ICD-10 Finland

Anaesthesia of skin

3.2

6.1

K13.03

ICD-10 Finland

Keilit UNS

5.7

6.1

X18

ICPC

Breast pain female

2.4

6.1

163

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.7

6.1

119

735

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.1

6.1

273

S22.3

ICD-10 Finland

Fracture of rib

1.6

6.1

154

1013

K04.08

ICD-10 Finland

Other specified pulpit

1.6

6.1

150

981

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.9

6.1

363

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.8

6.1

545

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

6.1

339

2588

L43.2

ICD-10 Finland

Lichenoid drug reaction

12.5

6.1

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

2.4

6.1

176

R09.3

ICD-10 Finland

Abnormal sputum

3.0

6.1

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.1

184

1259

R4130

NOMESCO Finland

Speech therapy

2.0

6.1

301

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

8.6

6.1

ZXA00

NOMESCO Finland

Right side

1.3

6.0

576

4738

N05AF03

ATC

chlorprothixene; systemic

2.2

6.0

234

R32

ICD-10 Finland

Unspecified urinary incontinence

1.9

6.0

371

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.7

6.0

106

637

R09.1

ICD-10 Finland

Pleurisy

2.3

6.0

189

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

3.1

6.0

I73.0

ICD-10 Finland

Raynaud syndrome

2.4

6.0

158

RP210, ,

NOMESCO Finland

10.0

6.0

D06AX01

ATC

fusidic acid; topical

1.5

6.0

184

1261

J03

ICD-10 Finland

Acute tonsillitis

2.3

6.0

202

D07XC01

ATC

betamethasone; topical

1.4

6.0

246

1783

B35.1

ICD-10 Finland

Tinea unguium

1.6

6.0

140

904

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026389) Candida sp identified in Specimen by Organism specific culture

279

305

10.18

235.21

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

610

2826

2.54

78.61

1.8

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1133

7369

1.99

59.36

3.3

2.6

54.72

71.58

u/l

0.91

1046

6811

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2050

16817

2.26

51.71

6.2

4.6

11.82

12.82

mm/h

2.59

1936

15716

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

857

5339

1.92

48.44

1.5

1.3

1.20

1.42

u/ml

0.33

239

1404

(3048689) Calprotectin [Mass/mass] in Stool

546

2951

2.09

45.89

2.4

145.92

131.96

ug/g

0.29

439

2344

(3037522) Nuclear Ab [Titer] in Serum

586

3261

2.04

45.45

1.5

1.3

455.34

528.07

titre

0.60

146

734

(40768804) Tissue Pathology biopsy report

1282

9265

1.79

43.52

2.6

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1596

12326

1.83

43.16

7.0

6.7

11.13

11.47

umol/l

0.41

1522

11760

(3015171) Extractable nuclear Ab [Units/volume] in Serum

235

900

2.78

42.89

1.4

1.2

1.09

0.88

u/ml

0.08

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1425

10674

1.79

42.34

2.4

2.2

96.30

96.38

pmol/l

0.02

770

5476

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1076

7434

1.79

42.12

2.6

2.2

174.26

208.54

u/l

0.68

1020

7022

(3013115) Eosinophils [#/volume] in Blood

1559

12047

1.79

41.06

8.0

6.7

0.19

e9/l

0.01

1400

10445

(3006315) Basophils [#/volume] in Blood

1514

11680

1.76

39.24

7.7

6.4

0.04

e9/l

0.34

1360

9969

(3001604) Monocytes [#/volume] in Blood

1511

11651

1.76

39.23

7.7

6.4

0.57

0.58

e9/l

0.77

1357

9945

(3031040) Bacteria [#/volume] in Urine by Automated count

1836

15033

1.85

38.41

6.7

5.2

507.35

2200.17

e6/l

1.68

215

(3021960) Folate [Moles/volume] in Serum or Plasma

1017

7063

1.75

37.94

1.8

1.7

20.63

20.68

nmol/l

0.03

872

5924

(3019198) Lymphocytes [#/volume] in Blood

1526

11883

1.74

37.40

7.8

6.5

1.84

1.91

e9/l

1.33

1397

10391

(3013650) Neutrophils [#/volume] in Blood by Automated count

1653

13169

1.76

37.31

10.9

9.8

4.06

4.09

e9/l

0.19

1485

11389

(3007164) IgA [Mass/volume] in Serum or Plasma

728

4639

1.81

36.19

1.7

1.5

2.34

2.43

g/l

0.51

445

2765

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1543

12146

1.72

35.41

7.9

7.3

1.22

mmol/l

0.99

1367

10507

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1395

10698

1.69

35.18

3.5

3.1

111.79

123.25

ug/l

1.53

1290

9951

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2044

17510

1.95

34.70

10.4

8.5

78.67

79.44

u/l

0.33

1947

16595

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

185

708

2.74

33.66

1.4

1.2

18.81

41.07

u/ml

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

919

6361

1.71

33.62

2.6

2.4

2.79

2.86

mg/l

0.31

788

5478

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

590

3607

1.83

33.18

1.6

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

684

4374

1.78

33.09

1.5

1.3

34.75

34.92

iu/ml

0.01

205

1370

(3024561) Albumin [Mass/volume] in Serum or Plasma

1383

10729

1.65

32.06

5.3

5.0

35.79

35.49

g/l

1.23

1299

10070

(40768797) Stomach Pathology biopsy report

556

3375

1.83

31.83

1.3

1.2

—

(3015736) pH of Urine

1275

9717

1.64

31.49

4.7

3.7

6.37

6.26

2.84

726

5421

(3019309) Folate [Moles/volume] in Red Blood Cells

643

4103

1.77

31.02

1.8

1072.40

1180.53

nmol/l

2.52

503

3091

(3035350) Ketones [Presence] in Urine by Test strip

1527

12207

1.65

30.92

5.4

4.2

9.30

4.13

estimate

0.35

276

2646

(3009261) Glucose [Presence] in Urine by Test strip

1534

12298

1.65

30.52

5.4

4.3

0.00

0.13

estimate

0.55

262

2478

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

746

5012

1.70

29.68

1.8

1.7

31140127.25

34466575.25

pmol/l

0.05

623

4149

(3018010) Neutrophils/Leukocytes in Blood

1372

10773

1.61

29.03

7.8

6.5

57.08

57.40

0.47

1307

10274

(3021601) Nitrite [Presence] in Urine by Test strip

1502

12069

1.62

28.77

5.3

4.2

0.00

estimate

0.50

268

2567

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1172

8875

1.61

28.73

4.9

4.0

24.75

119.28

ng/l

1.19

828

6376

(3013826) Glucose [Moles/volume] in Serum or Plasma

1650

13594

1.64

28.30

5.8

5.2

6.50

6.69

mmol/l

4.52

1579

12902

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1386

10950

1.60

28.25

7.5

6.7

1.22

1.21

mmol/l

0.60

1279

10107

(3019069) Monocytes/Leukocytes in Blood

1367

10765

1.60

28.24

8.2

6.7

8.81

8.87

0.35

1286

10068

(3022096) Basophils/Leukocytes in Blood

1363

10731

1.60

28.14

8.1

6.7

0.70

0.68

0.30

1281

10026

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

142

521

2.83

27.95

1.3

1.2

25.04

55.15

u/ml

—

(3006504) Eosinophils/Leukocytes in Blood

1360

10737

1.59

27.47

8.0

6.6

2.83

2.81

0.18

1279

10037

(3032080) INR in Blood by Coagulation assay

1358

10756

1.58

26.74

15.6

1.22

1.26

inr

1.51

1140

8945

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2002

17454

1.76

26.62

5.7

4.7

14.86

14.87

pmol/l

0.10

1855

16041

(3002030) Lymphocytes/Leukocytes in Blood

1376

10964

1.57

26.14

8.0

6.6

27.89

27.61

0.44

1314

10381

(3023420) DNA double strand Ab [Units/volume] in Serum

213

984

2.27

25.81

2.1

1.8

6.86

7.48

iu/ml

0.13

227

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

740

5116

1.64

25.64

1.9

1.8

1.00

1.30

mg/l

2.67

556

4005

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

162

671

2.51

25.06

1.4

1.2

5.17

2.97

u/ml

0.30

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

161

672

2.49

24.50

1.4

1.3

4.65

8.13

u/ml

0.63

112

(3003327) Ova and parasites identified in Stool by Light microscopy

176

778

2.36

23.60

1.8

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2235

20359

1.99

23.12

7.3

5.8

1.91

1.94

mu/l

0.45

2082

18825

(36660697) Celiac disease serology panel - Serum

331

1877

1.88

22.91

1.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1353

10953

1.52

22.35

2.9

2.5

78.89

78.75

nmol/l

0.06

1223

9859

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

600

4064

1.63

22.02

1.4

1.3

10.21

12.35

u/ml

0.24

223

1550

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2320

21485

2.23

21.96

23.2

17.0

22.30

24.30

mg/l

2.36

2010

17811

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

230

1178

2.05

21.36

1.1

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

133

547

2.51

20.88

1.3

1.2

1.31

4.73

u/ml

0.78

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

314

1809

1.84

20.57

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1688

14455

1.52

20.35

4.1

3.4

52.32

49.59

u/l

0.41

1586

13513

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

159

718

2.30

20.28

2.2

1.6

1.19

g/l

0.02

150

686

(3013139) Helicobacter pylori Ag [Presence] in Stool

289

1631

1.87

20.19

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1142

9065

1.48

19.83

5.3

4.2

2.30

0.34

estimate

0.41

222

2105

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

155

700

2.30

19.77

2.3

1.6

0.24

g/l

0.01

146

669

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

959

7373

1.49

19.41

3.2

1052.64

1322.84

ng/l

1.21

823

6357

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

258

1423

1.91

19.32

1.4

1.3

40.72

53.61

au/ml

0.47

102

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

275

1557

1.86

18.98

2.6

2.4

30.36

21.83

au/ml

0.34

146

(3019150) Specific gravity of Urine by Refractometry

732

5345

1.52

18.89

5.7

4.5

1.02

1.30

kg/l

0.50

510

3614

(3022948) Iron [Moles/volume] in Serum or Plasma

586

4101

1.56

18.25

2.6

2.7

13.25

12.76

umol/l

0.85

548

3813

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

981

7658

1.46

17.99

3.4

3.2

29.51

33.85

u/l

3.47

924

7211

(3019225) pH of Specimen

370

2329

1.69

17.69

4.5

4.4

7.37

7.36

0.51

271

1665

(3004616) Nuclear Ab [Presence] in Serum

291

2.88

17.22

1.3

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

850

6495

1.47

17.21

3.9

3.2

0.09

0.02

0.32

167

(3017732) Neutrophils [#/volume] in Blood

441

2928

1.62

17.07

3.4

3.3

4.64

4.70

e9/l

0.03

377

2535

(3026008) Bacteria identified in Urine by Culture

980

7712

1.45

16.93

3.9

3.5

—

(3022145) Colonoscopy Study observation

414

2714

1.63

16.86

1.4

1.3

—

(3045414) Leukocytes [Presence] in Urine

364

2318

1.67

16.59

2.3

2.2

0.00

0.01

estimate

0.78

475

(3005719) IgG [Mass/volume] in Serum or Plasma

300

1816

1.74

16.48

3.2

2.9

10.14

10.61

g/l

1.19

279

1667

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2217

20525

1.75

16.43

7.4

6.7

39.12

39.43

mmol/mol

1.09

2081

19154

(3011397) Hemoglobin [Presence] in Urine by Test strip

753

5661

1.47

16.40

5.1

4.0

0.60

0.15

—

(3007853) Bacteria identified in Skin by Aerobe culture

415

2747

1.61

16.20

2.1

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

541

3816

1.53

15.99

2.6

2.34

2.32

g/l

0.33

498

3517

(3019550) Sodium [Moles/volume] in Serum or Plasma

2341

22084

2.06

15.78

25.5

20.2

139.59

139.66

mmol/l

0.64

2311

21665

(3023103) Potassium [Moles/volume] in Serum or Plasma

2344

22123

2.08

15.77

25.6

20.4

3.96

3.97

mmol/l

0.88

2309

21663

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

221

1251

1.84

15.19

2.6

2.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

148

755

2.02

13.87

1.5

1.4

313.46

278.22

ug/g

1.14

443

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

285

1786

1.67

13.70

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

263

1615

1.70

13.64

2.2

1.9

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2235

20915

1.69

13.62

6.2

5.4

5.90

5.95

mmol/l

1.51

2055

19126

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

4.55

13.53

1.2

0.31

0.29

g/l

0.86

(3015377) Calcium [Moles/volume] in Serum or Plasma

1047

8575

1.38

13.43

3.5

2.36

mmol/l

0.03

929

7787

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

491

3511

1.50

13.33

2.6

2.7

22.68

22.22

0.31

453

3264

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

557

4090

1.47

13.23

2.2

1.9

—

(3025941) Bacteria identified in Stool by Culture

209

1213

1.79

13.22

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

373

2.41

13.03

1.7

1.8

0.66

0.81

g/l

0.68

302

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

243

2.76

13.01

1.3

1.1

34.57

40.63

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

317

2067

1.61

13.00

2.6

2.9

66.25

66.45

g/l

0.19

291

1892

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

337

2.48

12.98

1.2

1.1

3.40

12.00

u/ml

—

(3029937) Albumin [Presence] in Urine by Test strip

851

6779

1.39

12.73

5.5

4.4

0.00

estimate

1.74

251

2414

(3018095) Leukocytes [#/volume] in Urine

1055

8719

1.37

12.50

4.7

4.1

90.13

103.10

e6/l

0.15

780

6103

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

156

841

1.91

12.48

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

312

2046

1.60

12.48

4.1

3.3

4.54

4.50

kpa

0.15

305

1989

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

240

2.71

12.21

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

391

2712

1.52

12.19

8.5

7.1

—

(3012544) pH of Venous blood

360

2454

1.55

12.15

4.4

3.8

7.39

7.38

1.83

216

1384

(3021447) Carbon dioxide [Partial pressure] in Venous blood

357

2436

1.54

11.99

4.3

3.8

5.79

5.83

kpa

0.34

348

2372

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

116

572

2.08

11.94

1.1

2.75

5.87

eliau/ml

0.77

(3018418) pH of Serum or Plasma

912

7407

1.37

11.90

4.9

4.2

7.40

0.14

659

5370

(3012095) Magnesium [Moles/volume] in Serum or Plasma

548

4083

1.44

11.89

3.4

0.83

0.82

mmol/l

1.32

517

3841

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

202

1197

1.75

11.89

5.3

3.9

48.70

47.73

0.21

202

1171

(3036481) Cortisol [Moles/volume] in Serum or Plasma

339

2291

1.56

11.88

2.5

2.2

358.09

378.53

nmol/l

1.05

302

2115

(3002032) Base excess in Venous blood by calculation

348

2372

1.54

11.73

4.5

3.8

1.92

1.91

mmol/l

0.01

311

2066

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

214

1294

1.72

11.72

3.9

2.8

0.63

0.62

0.17

214

1287

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

402

2829

1.50

11.67

5.2

5.1

33.49

33.09

0.28

266

1842

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

385

2693

1.51

11.49

2.9

2.7

7.10

8.08

umol/l

0.58

332

2381

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2376

22778

2.02

11.46

28.7

22.3

75.70

76.41

umol/l

0.51

2353

22515

(40768443) Skin Pathology biopsy report

182

1059

1.78

11.41

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

274

1783

1.60

11.28

2.3

2.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

214

1308

1.70

11.27

3.9

2.8

1.15

1.18

0.21

214

1300

(3024139) IgG subclass 3 [Mass/volume] in Serum

222

2.70

11.20

1.6

1.5

0.39

0.40

g/l

0.13

166

(3028192) IgG subclass 2 [Mass/volume] in Serum

222

2.70

11.20

1.6

1.5

2.85

2.91

g/l

0.10

166

(3027135) IgG subclass 1 [Mass/volume] in Serum

222

2.70

11.20

1.6

1.5

6.70

6.90

g/l

0.10

167

(4062490) Immunoglobulin typing, IgG

223

2.69

11.11

1.6

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

156

874

1.84

11.09

1.7

2.2

248.85

616.55

ug/l

0.91

144

830

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

201

1214

1.71

11.06

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

643

4992

1.39

10.90

5.4

4.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1459

12818

1.34

10.89

3.2

2.9

—

(3005322) IgE [Units/volume] in Serum or Plasma

239

1519

1.63

10.83

1.5

1.3

149.83

201.62

u/ml

0.78

228

1401

(40758558) Short blood count panel - Blood

872

7116

1.35

10.76

6.9

6.3

—

(3002582) Erythrocytes [#/volume] in Urine

931

7681

1.34

10.64

4.0

3.5

67.32

69.65

e6/l

0.02

736

5842

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

601

4632

1.39

10.60

4.5

3.9

252.81

406.32

ng/l

1.00

457

3683

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

167

2.91

10.56

1.5

1.4

—

317.33

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

550

4179

1.41

10.54

3.4

3.0

1.49

1.26

e6/l

0.30

326

2228

(3028026) IgM [Mass/volume] in Serum or Plasma

229

1450

1.64

10.53

2.1

1.9

1.24

1.42

g/l

0.72

212

1326

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

136

3.12

10.45

2.0

2.2

186.42

211.51

e6/l

0.40

116

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

732

5837

1.36

10.43

2.7

2.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2355

22574

1.85

10.41

16.6

12.8

25.22

25.37

u/l

0.18

2292

21944

(3017315) Amylase [Enzymatic activity/volume] in Urine

116

3.31

10.40

1.2

1.3

242.77

351.08

u/l

0.36

106

(3045424) Erythrocytes [Presence] in Urine

192

1165

1.70

10.39

2.2

0.00

0.70

estimate

0.51

361

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

316

2.35

10.38

1.6

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

311

2.35

10.29

1.6

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

134

3.09

10.06

1.9

2.2

421.09

553.23

e6/l

0.76

107

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2199

20747

1.53

10.02

19.9

16.6

79.34

78.82

ml/min/173m2

0.61

2080

19297

(3030981) Hyaline casts [#/volume] in Urine by Automated count

286

1934

1.54

9.94

2.3

2.4

0.32

0.48

e6/l

0.84

272

1847

(3009445) Proteinase 3 Ab [Units/volume] in Serum

167

988

1.74

9.90

1.7

1.5

21.72

11.27

iu/ml

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

196

2.69

9.88

1.8

1.5

21.09

22.39

u/ml

0.08

(3026493) Urate [Moles/volume] in Serum or Plasma

741

5960

1.35

9.88

2.7

2.8

330.80

339.57

umol/l

1.44

651

5223

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1248

10810

1.31

9.85

3.2

2.8

—

estimate

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

148

850

1.79

9.72

2.7

—

(3023368) Bacteria identified in Blood by Culture

802

6552

1.33

9.55

4.7

4.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

287

1962

1.52

9.48

2.8

2.4

4.51

7.12

ug/l

3.03

240

1739

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.40

9.45

1.5

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.40

9.45

1.5

1.3

—

(3042936) Bacteria identified in Isolate by Culture

455

3403

1.41

9.45

2.1

2.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

150

873

1.76

9.42

1.7

1.6

12.33

15.84

u/ml

0.63

177

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

130

726

1.83

9.37

1.5

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2143

20166

1.46

9.35

5.1

4.4

1.30

1.29

mmol/l

0.41

1968

18429

(3005988) Vibrio sp identified in Specimen by Organism specific culture

301

2.26

8.79

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

314

2.23

8.78

1.7

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

908

7617

1.30

8.76

2.8

2.5

—

(3000850) Epithelial cells [#/volume] in Urine

663

5336

1.33

8.59

3.0

2.8

4.70

6.29

e6/l

3.43

608

4838

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

233

1558

1.55

8.51

1.2

172.42

144.03

u/ml

0.37

587

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

299

2.24

8.50

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

299

2.24

8.50

1.7

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

326

2.18

8.44

1.3

—

(3007461) Platelets [#/volume] in Blood

2394

23189

1.92

8.42

34.6

26.0

254.06

252.35

e9/l

0.57

2365

22727

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

377

2782

1.42

8.38

4.4

227.36

244.85

u/l

2.14

357

2628

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2394

23192

1.92

8.37

34.5

25.9

91.29

91.28

0.01

2378

22940

(3035941) MCH [Entitic mass]

2394

23194

1.92

8.33

34.5

25.8

30.31

30.32

0.09

2378

22941

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

415

3117

1.40

8.33

2.0

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

2394

23195

1.92

8.32

34.6

25.9

4.43

4.44

e12/l

0.72

2359

22659

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2394

23195

1.92

8.32

35.1

26.5

39.83

39.96

0.57

2378

22931

(3010813) Leukocytes [#/volume] in Blood

2394

23198

1.91

8.27

34.7

26.0

6.76

6.72

e9/l

0.32

2362

22655

(3000963) Hemoglobin [Mass/volume] in Blood

2394

23199

1.91

8.25

34.9

26.1

133.29

133.63

g/l

0.58

2379

22952

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

332

2409

1.44

8.09

2.3

2.2

0.22

0.21

g/l

1.11

315

2246

(3004716) Salmonella sp identified in Stool by Organism specific culture

165

1029

1.65

8.08

1.5

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

114

641

1.82

8.07

1.3

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

415

2.01

7.97

1.2

1.3

486.67

353.53

titre

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

142

2.77

7.97

1.5

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

113

637

1.81

7.94

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

774

6426

1.30

7.88

4.5

3.6

0.02

0.19

estimate

0.72

215

2033

(42529406) Shigella sp [Presence] in Stool by Culture

114

647

1.80

7.84

1.3

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

263

1842

1.48

7.70

2.6

2.8

67.89

65.06

ml/min/173m2

0.58

114

815

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

144

879

1.68

7.66

2.5

2.0

—

(3023520) Reticulocytes [#/volume] in Blood

301

2167

1.44

7.64

2.3

2.7

68.31

70.12

e9/l

0.41

225

1590

(36304419) Bacteria [Presence] in Urine

760

6319

1.29

7.60

3.8

3.3

318.75

492.55

estimate

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

141

2.72

7.51

1.6

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2226

21261

1.46

7.40

6.1

5.3

4.63

4.65

mmol/l

0.46

2081

19779

(3030467) Casts [#/volume] in Urine by Automated count

794

6659

1.28

7.37

3.9

3.3

0.27

0.44

e6/l

3.52

613

4885

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

108

616

1.79

7.33

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

126

755

1.70

7.20

1.4

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2211

21117

1.43

7.09

6.0

5.2

1.50

1.49

mmol/l

0.28

2055

19514

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

132

808

1.67

6.98

2.2

1.9

—

(3017354) Segmented neutrophils/Leukocytes in Blood

233

2.26

6.94

3.2

3.9

62.39

56.51

1.13

208

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

483

3821

1.33

6.87

3.5

3.1

4.47

2.73

e6/l

0.38

261

1859

(3020891) Body temperature

172

1129

1.56

6.84

6.2

4.4

36.92

°c

0.10

172

1120

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

100

571

1.78

6.78

1.2

1.1

5.87

4.92

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

441

3451

1.34

6.75

2.1

1.8

—

(3028433) Virus identified in Specimen by Culture

3.31

6.69

1.0

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2249

21591

1.45

6.58

6.9

6.1

2.68

2.69

mmol/l

0.35

2093

20005

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

252

2.17

6.55

2.2

1.6

—

(3011412) CD3 cells [#/volume] in Blood

202

2.30

6.45

1.8

2.1

1066.82

1207.59

e6/l

0.57

179

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

310

2316

1.39

6.36

2.7

2.4

31.99

39.53

u/l

2.01

260

1941

(3033099) Centromere Ab [Titer] in Serum

4.07

6.35

1.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

119

2.71

6.34

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.59

6.31

1.4

2.0

2.69

0.21

e9/l

0.46

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

138

2.56

6.20

2.3

2.1

0.70

0.72

e9/l

0.06

132

(3022621) pH of Urine by Test strip

258

1878

1.42

6.16

3.5

2.9

6.13

6.07

0.46

170

1274

(3027945) Reticulocytes/Erythrocytes in Blood

362

2790

1.35

6.10

2.4

2.7

1.74

1.82

0.75

326

2476

(3023511) Choriogonadotropin [Units/volume] in Urine

294

2.03

6.07

1.8

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

217

1537

1.45

6.01

2.0

1.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.94

6.00

1.1

180.38

463.54

ng/l

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

152

1001

1.55

5.99

2.0

39.60

39.47

u/l

0.03

137

889

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

378

2943

1.34

5.95

2.1

1.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

297

2228

1.38

5.94

6.4

7.6

1.39

1.33

mmol/l

0.46

288

2193

(3007930) Methemoglobin/Hemoglobin.total in Blood

149

985

1.55

5.78

4.2

5.5

0.88

0.87

0.09

143

926

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.93

5.73

1.1

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

287

2.01

5.72

1.2

1.6

20.09

28.36

ng/l

1.12

287

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

234

2.12

5.66

2.2

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

311

2369

1.36

5.65

1.8

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

934

8170

1.23

5.64

3.7

3.4

7.09

7.16

mmol/l

0.16

795

6890

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

604

5035

1.26

5.64

2.9

3.0

2.46

mmol/l

0.17

535

4540

(3049717) Cytology report of Urine Cyto stain

129

830

1.58

5.64

2.5

2.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

130

840

1.58

5.58

2.4

1.9

—

(3000330) Specific gravity of Urine by Test strip

174

1199

1.49

5.56

4.6

3.5

1.02

ratio

0.92

160

1091

(3017181) Myelocytes/Leukocytes in Blood

284

2145

1.37

5.45

4.6

0.63

0.91

1.85

630

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

310

2375

1.35

5.43

2.0

1.8

1.47

0.01

269

2050

(3026782) Osmolality of Urine

553

4583

1.27

5.40

3.6

3.0

506.84

517.59

mosm/kgh2o

0.56

489

4004

(3020779) Urea [Moles/volume] in Serum or Plasma

286

2167

1.36

5.38

7.2

7.6

8.73

9.88

mmol/l

2.15

274

2079

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

157

1073

1.49

5.24

4.2

5.3

1.50

1.56

0.45

151

1011

(3028679) Herpes simplex virus Ab [Presence] in Serum

114

2.56

5.21

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

446

3617

1.28

5.18

1.9

2.2

29.67

29.53

0.18

430

3515

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

255

1911

1.37

5.14

3.0

3.1

170.28

200.11

ng/l

0.67

232

1751

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1045

1.49

5.13

2.7

2.4

3.53

3.73

g/l

0.92

139

952

(3003458) Phosphate [Moles/volume] in Serum or Plasma

409

3284

1.29

5.13

6.7

5.8

1.01

1.04

mmol/l

1.67

382

3024

(3008757) Leukocyte morphology finding [Identifier] in Blood

237

2.05

5.11

4.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

207

1499

1.42

5.11

2.9

3.5

4.40

4.48

pmol/l

0.63

179

1329

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1046

1.49

5.11

2.7

2.4

7.11

7.43

g/l

1.70

139

952

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

1046

1.49

5.11

2.7

2.4

4.27

4.24

g/l

0.25

139

951

(3037121) Protein [Mass/volume] in Urine

126

829

1.55

5.03

3.9

3.4

306.56

368.65

mg/l

0.22

348

(3019977) pH of Arterial blood

357

2825

1.31

4.99

6.5

7.9

7.42

0.21

201

1548

(3011897) Casein IgE Ab [Units/volume] in Serum

5.02

4.94

1.1

1.2

0.52

1.78

u/ml

0.50

(3021440) Promyelocytes/Leukocytes in Blood

270

2057

1.35

4.90

4.7

0.01

0.12

5.83

541

(3034274) Bile acid [Moles/volume] in Serum --fasting

214

2.08

4.89

2.2

2.0

6.82

7.39

umol/l

0.09

148

(3003396) Base excess in Arterial blood by calculation

354

2806

1.31

4.88

6.4

7.8

1.31

1.03

mmol/l

0.68

297

2318

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

357

2836

1.30

4.84

6.5

7.9

5.18

5.11

kpa

0.74

335

2739

(3027801) Oxygen [Partial pressure] in Arterial blood

357

2837

1.30

4.83

6.5

7.9

12.13

12.36

kpa

0.44

335

2739

(3006270) Folate [Moles/volume] in Blood

170

2.19

4.75

1.3

1.2

355.27

383.98

nmol/l

0.32

152

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

410

1.75

4.74

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

112

728

1.56

4.74

1.5

0.04

9.30

iu/ml

0.50

131

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

148

1023

1.48

4.70

2.6

2.0

—

(3004809) Band form neutrophils/Leukocytes in Blood

360

1.80

4.67

3.3

4.0

0.80

1.47

1.83

328

(3000991) Gas panel - Venous blood

276

2126

1.34

4.66

7.5

8.9

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

473

1.69

4.64

5.6

5.3

381.14

807.14

iu/ml

0.58

(3002179) Metamyelocytes/Leukocytes in Blood

267

2050

1.34

4.61

4.7

4.4

0.50

0.68

1.15

597

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

392

1.76

4.58

2.1

1.8

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

227

2.00

4.56

2.5

19.69

42.49

iu/ml

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

126

849

1.51

4.54

5.2

4.2

24.72

24.95

mmol/l

0.39

111

790

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

291

1.87

4.52

1.9

2.3

31.26

22.48

mg/l

0.32

105

(3016502) Oxygen saturation in Arterial blood

319

2521

1.30

4.50

6.6

8.2

96.19

95.60

1.68

302

2443

(1761482) Bacteria [#/volume] in Urine by Culture

547

1.63

4.49

5.9

4.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

143

993

1.47

4.45

2.8

2.5

2.66

2.94

g/l

2.66

129

899

(3020682) Albumin/Creatinine [Ratio] in Urine

895

7941

1.20

4.39

4.2

4.1

7.92

8.55

mg/mmol

0.16

516

4843

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

150

2.22

4.37

1.1

—

(4024509) Urine culture

164

1175

1.42

4.33

2.1

2.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

131

901

1.48

4.29

2.6

2.5

9.97

10.33

g/l

0.39

114

798

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

610

1.58

4.27

2.0

2.1

11.07

12.50

mg/l

1.16

568

(3012516) Albumin [Mass/volume] in Urine

879

7803

1.20

4.26

3.6

3.5

40.52

44.81

mg/l

0.30

524

4867

(21494890) Protein electrophoresis panel - 24 hour Urine

247

1.92

4.26

1.7

2.0

—

(3008037) Lactate [Moles/volume] in Venous blood

580

1.59

4.22

3.6

3.0

1.48

1.57

mmol/l

0.42

561

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

3.15

4.20

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

131

908

1.47

4.14

1.4

26.44

30.59

iu/l

0.75

109

773

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

128

2.28

4.13

1.2

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.00

4.12

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

195

2.02

4.08

1.5

355.27

324.61

mu/l

0.23

153

(3008152) Bicarbonate [Moles/volume] in Arterial blood

197

1475

1.36

4.03

7.7

6.9

25.26

24.52

mmol/l

2.22

184

1413

(44816559) Phosphatidylethanol [Mass/volume] in Blood

126

873

1.47

4.00

1.7

0.36

0.32

mg/l

0.32

398

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.83

3.95

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.83

3.95

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

180

1334

1.38

3.93

4.5

3.8

1.38

1.91

mmol/l

1.07

135

1015

(3032057) Clostridioides difficile [Presence] in Stool

3.14

3.93

2.1

2.0

—

(3025159) Blasts/Leukocytes in Blood

264

2074

1.31

3.90

5.0

4.9

0.03

0.10

1.47

505

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

245

1905

1.32

3.90

1.6

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

568

1.57

3.89

3.1

2.1

963.44

5177.41

u/l

2.86

240

(3009214) Lutropin [Units/volume] in Serum or Plasma

498

1.61

3.86

1.3

1.4

12.16

10.97

u/l

0.28

392

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

200

1.97

3.82

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

368

1.70

3.82

1.1

8.71

19.67

au/ml

—

(3002256) Pathology report gross observation

375

3086

1.25

3.82

1.3

—

(3009343) pH of Capillary blood

200

1518

1.35

3.76

4.6

4.0

7.42

0.00

172

1281

(3007566) Smooth muscle Ab [Titer] in Serum

662

1.52

3.75

1.2

264.29

94.63

titre

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.65

3.73

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.65

3.73

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.65

3.73

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.65

3.73

1.1

1.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.46

3.71

3.0

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.46

3.71

3.0

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.46

3.71

2.0

2.5

220.33

36928.77

u/ml

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

115

2.27

3.71

2.7

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

115

2.27

3.71

2.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

115

2.27

3.71

1.0

1.1

1635.92

1543.27

miu/ml

0.16

115

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

115

2.27

3.71

2.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

115

2.27

3.71

2.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

543

1.57

3.71

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.02

3.68

1.1

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

442

1.62

3.67

1.8

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

162

2.05

3.65

1.2

1.1

38.11

38.88

mg/l

0.03

134

(3038515) Glucose [Moles/volume] in Venous blood

482

1.59

3.64

3.8

3.2

7.01

7.57

mmol/l

1.28

465

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.43

3.63

3.0

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

204

1.93

3.63

2.5

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

204

1.93

3.63

2.5

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

204

1.93

3.63

2.5

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

382

1.67

3.61

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

414

1.64

3.57

4.6

2.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

257

2037

1.29

3.56

4.5

3.8

88.44

87.72

ng/l

0.05

223

1739

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.66

3.56

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

7.80

3.56

1.0

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

463

1.59

3.51

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

221

1.87

3.50

3.8

5.3

406.45

42.96

u/ml

0.43

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

207

1.90

3.49

1.5

1.3

—

(21494815) CD4 cells/Lymphocytes in Specimen

186

1.95

3.48

1.4

2.0

44.36

39.11

1.56

186

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.38

3.48

2.5

2.7

190.40

163.17

umol/l

—

(3028707) Methadone [Presence] in Urine by Screen method

251

1.81

3.46

4.3

2.1

—

(3022313) Gas panel - Capillary blood

146

1070

1.39

3.44

4.9

4.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

194

1.92

3.44

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

3.39

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

531

1.54

3.39

1.5

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.45

3.38

4.1

2.3

0.62

mmol/l

0.05

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

202

1562

1.32

3.37

4.6

4.0

5.07

5.18

kpa

1.18

188

1508

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

184

1404

1.34

3.37

3.6

3.9

30.86

75.11

u/ml

3.02

177

1354

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

203

1.89

3.35

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.72

3.32

1.1

—

(3014271) Vancomycin [Susceptibility]

108

2.23

3.32

3.2

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

205

1594

1.31

3.29

2.1

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

127

918

1.40

3.26

2.8

2.6

0.87

1.18

g/l

0.51

107

789

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.59

3.26

1.5

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

593

1.50

3.26

1.4

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

227

1.82

3.24

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

134

979

1.39

3.24

1.8

1.9

2.09

1.63

ug/l

0.20

123

870

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

635

1.48

3.23

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

181

1387

1.33

3.23

2.7

2.3

12.30

12.79

nmol/l

0.35

164

1243

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

151

1126

1.36

3.22

1.7

1.8

1.60

1.56

g/l

0.20

130

979

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.51

3.21

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

498

1.54

3.21

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

653

1.47

3.20

1.9

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

150

2.01

3.20

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

403

1.60

3.20

1.9

1.4

165.17

155.09

au/ml

0.24

118

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

609

5353

1.18

3.15

6.3

5.6

2.06

2.60

ug/l

1.45

551

4820

(37208534) Antinuclear antibody arbitrary concentration in serum

2.48

3.12

1.1

1.0

—

(3019230) Fractional oxyhemoglobin in Venous blood

550

1.51

3.12

3.1

2.8

63.40

60.53

0.61

545

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

298

1.69

3.10

1.2

1.3

—

nmol/l

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

152

1.99

3.09

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.01

3.08

1.4

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

360

3022

1.22

3.05

1.8

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

434

3711

1.21

3.05

1.7

1.5

—

(3044927) Protein electrophoresis panel - Urine

254

1.75

3.05

1.4

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

7.52

3.05

5.3

4.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

472

1.54

3.05

1.2

—

(3024471) HLA-A [Type]

2.59

3.04

1.1

1.0

—

(3042517) Benzodiazepines panel - Urine

5.85

3.02

2.1

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

182

1.88

3.01

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

119

865

1.39

2.98

4.3

3.5

33.21

60.16

mg/l

1.22

104

744

(3033658) Prothrombin time (PT) actual/Normal

675

6008

1.17

2.98

4.8

4.1

88.77

90.17

0.74

657

5872

(3021589) Normoblasts [#/volume] in Blood

1099

10142

1.15

2.98

13.7

12.0

0.00

e9/l

0.40

932

8266

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

190

1.85

2.97

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

190

1.85

2.97

1.1

—

(3008898) HLA-B27 [Presence]

104

739

1.43

2.97

1.1

—

(4035726) Immunohistochemistry procedure

262

2133

1.26

2.95

1.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

155

1.95

2.94

1.2

1.1

259.36

272.08

mg/l

0.12

132

(3047181) Lactate [Moles/volume] in Blood

691

1.44

2.92

4.5

6.6

1.24

1.30

mmol/l

0.23

608

(4034850) Laboratory test

684

1.44

2.89

12.1

10.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.38

2.89

2.4

151.56

151.21

nmol/l

0.01

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

185

1.85

2.87

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

5.40

2.87

1.4

1.6

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

5.40

2.87

1.9

1.3

0.08

1.87

mg/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

178

1.87

2.86

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

2.03

2.86

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

456

1.53

2.84

1.3

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

118

865

1.38

2.83

4.3

3.5

51.33

120.05

mg/l

0.56

103

743

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

246

1.72

2.80

3.9

4.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

515

1.49

2.79

2.7

2.9

29.47

33.49

umol/l

1.17

463

(3024932) HLA-DR beta [Type]

2.55

2.78

1.2

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

434

1.53

2.78

2.0

1.7

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

117

2.06

2.77

1.1

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

124

2.03

2.76

1.0

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

340

1.60

2.74

1.1

2.59

3.61

u/ml

0.50

175

(3002173) Hemoglobin [Mass/volume] in Arterial blood

284

2356

1.23

2.71

7.1

8.7

119.73

119.97

g/l

0.07

274

2306

(1001926) Buprenorphine [Presence] in Urine by Screen method

453

1.52

2.71

3.3

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

132

1.98

2.70

1.4

1.3

124.81

136.54

nmol/l

0.60

132

(3020876) Protein [Mass/time] in 24 hour Urine

287

1.65

2.70

2.4

2.3

0.73

1.04

g/24h

0.82

168

(40763480) Human metapneumovirus Ag [Presence] in Specimen

6.01

2.70

1.5

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

637

1.43

2.66

1.5

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

579

1.45

2.65

3.1

1.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.15

2.64

1.2

1.1

0.31

2.02

u/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

310

2604

1.22

2.63

3.9

4.2

31.72

17.43

ug/l

0.27

265

2122

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

191

1.79

2.62

1.1

1.0

281.94

288.11

mg/l

0.15

169

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

106

775

1.38

2.61

3.9

3.3

3.14

3.88

ratio

0.22

447

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.61

2.57

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

142

1.91

2.55

4.6

6.9

45.92

159.86

ug/l

0.40

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

171

1.82

2.54

1.1

22.73

6.24

nmol/l

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.61

2.53

1.2

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

216

1.72

2.52

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

662

1.40

2.50

1.6

1.5

—

(3027008) Opiates [Presence] in Urine

579

1.43

2.47

3.1

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.96

2.45

1.2

1.1

1.46

1.17

u/l

0.42

(3010838) Calcium [Moles/time] in 24 hour Urine

464

1.48

2.45

1.8

1.9

4.88

4.90

mmol/24h

0.02

396

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

631

1.41

2.44

1.9

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

312

1.58

2.41

1.0

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

541

1.44

2.39

1.5

8.16

41.06

e6/l

1.30

396

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

575

1.42

2.38

1.4

1.5

136.83

231.38

pmol/l

1.20

560

(3008536) Aspergillus sp Ab [Presence] in Serum

2.62

2.36

1.9

1.5

—

(3028300) Cannabinoids [Presence] in Urine

585

1.42

2.35

3.1

1.7

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

154

1.83

2.34

1.4

1.5

1.32

1.12

promille

0.22

120

(3014148) Varicella zoster virus Ab [Titer] in Serum

252

1.64

2.34

1.1

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

544

1.43

2.33

1.5

662.77

904.49

e6/l

0.15

426

(3016879) Cocaine [Presence] in Urine

536

1.43

2.33

3.2

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

520

1.44

2.31

2.4

3.5

822.26

837.54

u/ml

0.01

483

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

316

1.56

2.30

1.9

2.5

184.54

55.20

u/ml

0.32

310

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

223

1.67

2.28

2.2

2.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

113

1.96

2.25

1.1

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.34

2.21

1.2

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

157

1.79

2.21

1.3

2.1

—

(3005570) Glucose [Moles/volume] in Urine

233

1.64

2.20

2.2

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

377

1.50

2.18

1.4

1.5

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

103

774

1.35

2.18

2.7

2.4

0.00

0.02

g/l

0.66

693

(1761868) Lipid panel - Serum or Plasma

732

7982

0.88

2.15

3.8

3.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

371

1.49

2.13

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

487

4333

1.15

2.12

5.1

4.6

22.21

21.46

0.51

229

2121

(4133840) Spirometry

2.46

2.10

1.2

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.21

2.09

1.6

2.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

332

1.52

2.09

1.1

0.46

1.14

u/ml

0.99

139

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1020

9525

1.12

2.07

1.9

2.0

1.38

1.35

mmol/l

0.49

860

7960

(3027944) Amphetamines [Presence] in Urine

575

1.39

2.06

2.9

1.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

199

1.67

2.05

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.08

2.01

1.0

1.2

—

(3008295) Osmolality of Serum or Plasma

295

1.54

2.01

1.7

1.3

275.70

276.24

mosm/kgh2o

0.06

225

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.01

2.00

1.4

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.82

2.00

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.82

2.00

1.1

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

665

1.35

1.98

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

119

1.86

1.97

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.34

1.96

2.0

1.0

—

(3044889) 12 lead EKG panel

1639

15748

1.12

1.95

5.0

4.3

0.33

2730.57

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.55

1.94

4.0

3.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.97

1.93

1.0

—

(40768441) Liver Pathology biopsy report

172

1.69

1.93

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.45

1.93

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

103

791

1.32

1.92

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

315

1.50

1.91

1.3

1.2

0.20

0.25

nmol/l

0.31

245

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

227

1.59

1.90

1.6

1.5

—

(21494434) Karyotype in Bone marrow

220

1.60

1.88

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.65

1.86

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.65

1.86

1.4

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.65

1.86

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.65

1.86

1.4

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

344

1.46

1.80

1.6

1.7

—

(3042733) HLA Ab [Presence] in Serum

2.17

1.77

5.3

4.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

626

1.34

1.77

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

109

1.84

1.77

1.4

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

697

1.32

1.75

2.8

2.5

0.00

g/l

-0.00

654

(3029634) Reagin Ab [Titer] in Serum by VDRL

297

1.49

1.75

1.6

2.0

—

8.14

—

(3037756) Immunofixation for Serum or Plasma

541

1.36

1.75

1.5

1.6

—

(3036489) Thrombin time

112

883

1.28

1.74

1.8

2.2

21.29

21.20

0.06

791

(3021879) Hepatitis B virus core Ab [Presence] in Serum

189

1581

1.21

1.74

1.5

1.4

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

166

1372

1.22

1.72

6.9

10.9

16.25

15.81

1.41

156

1326

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.67

1.72

1.1

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.06

1.70

1.6

—

(21494755) Public health laboratory ask at order entry panel

126

1557

0.80

1.69

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

308

1.47

1.68

1.4

0.25

0.33

nmol/l

0.96

234

(3045142) Bone marrow Pathology biopsy report

292

1.48

1.67

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

520

1.36

1.66

1.5

—

(3011985) Renin [Units/volume] in Plasma

342

1.44

1.66

1.8

1.4

66.93

59.77

mu/l

0.10

307

(3036603) Volume of Urine

180

1.62

1.66

1.8

1.5

2445.03

1829.60

2.14

175

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.59

1.66

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

2.59

1.66

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

651

1.32

1.65

1.6

1.4

—

(3003181) Sodium [Moles/volume] in Urine

521

1.35

1.65

1.4

58.29

58.75

mmol/l

0.03

422

(3000475) Leukocytes [#/volume] in Synovial fluid

627

1.32

1.62

2.0

1.6

15280.72

12236.15

e6/l

0.21

440

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.87

1.60

1.1

157.96

216.43

iu/ml

0.50

(4027681) Cerebrospinal fluid IgG ratio and IgG index

121

1.74

1.58

1.3

1.2

0.48

0.53

ratio

0.89

(3024891) Influenza virus A+B Ag [Presence] in Specimen

560

1.33

1.58

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

248

1.50

1.55

1.1

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

107

1.78

1.54

1.1

1.3

138.63

168.08

mmol/24h

0.87

107

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

476

1.35

1.53

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

476

1.35

1.53

1.5

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

175

1474

1.20

1.53

7.4

9.7

24.49

24.40

mmol/l

0.13

166

1450

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

660

1.30

1.52

1.8

2.1

3.43

12.89

iu/l

0.53

259

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

749

1.28

1.51

2.7

2.5

0.00

g/l

-0.00

655

(3016018) Differential panel - Cerebral spinal fluid

266

1.47

1.51

1.3

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.16

1.50

1.2

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

1.61

1.49

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.07

1.49

1.4

1.0

—

(3034426) Prothrombin time (PT)

2.01

1.48

1.2

1.4

26.54

28.90

1.33

(3024869) Neuronal Ab [Presence] in Serum

2.44

1.48

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

253

1.47

1.43

1.1

0.29

4.30

u/ml

3.30

109

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

338

1.40

4.7

6.8

11.24

12.26

mg/l

0.53

315

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

238

1.48

1.39

1.1

2.31

0.16

u/ml

0.44

(3010726) Horse dander IgE Ab [Units/volume] in Serum

313

1.41

1.39

1.1

1.06

1.50

u/ml

0.29

162

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.42

1.39

1.0

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.42

1.39

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

330

1.40

1.39

1.3

1.2

3.32

4.83

u/ml

0.57

143

(4281824) Cell count and differential, peritoneal fluid

287

0.59

1.38

1.4

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

596

0.72

1.37

1.2

1.1

0.60

0.63

ratio

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.80

1.37

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

289

1.43

1.37

1.1

1.13

2.39

eliau/ml

1.82

113

(3023419) Bacteria identified in Sputum by Culture

340

1.39

1.36

2.9

2.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

273

1.44

1.35

1.1

1.86

2.99

u/ml

0.42

136

(3006442) Creatine [Moles/volume] in Serum or Plasma

143

1.61

1.35

1.3

1.5

128.74

80.30

umol/l

0.57

143

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

409

1.35

1.1

0.36

2.18

u/ml

3.13

224

(40762365) Oxygen content in Arterial blood by calculation

0.00

1.34

0.0

2.9

—

15.43

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

463

1.33

1.32

2.5

1.8

0.90

0.85

nmol/l

0.18

388

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.10

1.30

1.2

1.5

1.18

mmol/l

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

267

1.43

1.30

2.3

3.3

35.58

25.29

nmol/l

0.10

262

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

421

1.34

1.29

1.6

1.3

243.76

274.57

u/ml

0.35

235

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

177

1.53

1.29

1.1

1.0

302.76

305.25

ng/l

0.02

117

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

178

1.52

1.26

1.1

1.0

949.88

709.62

ng/l

1.39

114

(40768446) Kidney Pathology biopsy report

1.82

1.25

1.9

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

312

1.38

1.24

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.40

1.24

1.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

195

1.49

1.24

1.1

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

187

1.50

1.24

1.1

380.00

173.87

titre

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

179

1.51

1.23

1.1

1.0

30.49

43.47

ng/l

1.58

117

(3003740) Influenza virus B Ag [Presence] in Specimen

347

1.36

1.23

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

399

1.34

1.22

1.7

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.05

1.22

13.9

8.0

8.45

5.24

kpa

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

196

1.49

1.21

1.4

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.63

1.21

1.2

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

348

1.36

1.21

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.11

1.18

1.1

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

324

1.36

1.18

1.6

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

324

1.36

1.18

1.6

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

324

1.36

1.18

1.6

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

324

1.36

1.18

1.6

1.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.93

1.17

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

190

1.48

1.16

1.4

1.2

0.61

1.39

u/ml

0.55

101

(3035933) Granulocytes/Leukocytes in Blood

500

1.29

1.15

3.2

55.76

57.62

0.48

500

(3034092) Cytoplasmic Ig cells/cells in Blood

2.50

1.15

35.0

10.3

0.20

0.21

—

(3050794) Legionella sp Ab [Presence] in Serum

2.50

1.15

1.0

—

(4212803) Bone marrow aspirate examination

2.50

1.15

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

207

1.45

1.15

1.5

1.1

113.97

107.91

pmol/l

0.41

207

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1808

17648

1.09

1.15

29.7

22.0

331.40

331.56

g/l

0.33

1803

17549

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.81

1.15

1.3

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.81

1.15

1.4

7.19

7.26

mmol/l

0.02

(3042631) Mycobacterium sp identified in Specimen

326

1.36

1.14

2.0

2.9

—

(3039000) Anion gap in Blood by calculation

484

1.29

1.13

5.1

7.7

10.93

11.24

mmol/l

0.35

435

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.75

1.13

1.1

1.2

—

(3018572) Chloride [Moles/volume] in Blood

485

1.29

1.11

5.1

7.7

105.49

105.23

mmol/l

0.18

436

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

311

1.36

1.10

1.3

337.41

322.68

pmol/l

0.08

265

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

647

0.77

1.07

1.2

1.52

1.56

g/l

0.64

647

(3047189) Immunofixation for 24 hour Urine

121

1.57

1.05

1.5

1.6

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

340

1.33

1.05

1.3

1.2

4.81

3.24

u/ml

0.22

118

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.79

1.04

1.1

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.96

1.03

1.4

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.28

1.03

4.2

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.28

1.03

1.4

1.5

41.60

44.91

umol/l

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.88

1.00

1.9

2.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.00

1.00

5.0

8.1

11.07

10.50

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

107

1.59

0.99

2.4

1.7

41.81

39.62

g/l

0.85

107

(3025130) Human papilloma virus identified in Specimen

326

1.32

0.99

1.6

1.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.84

0.98

1.9

2.1

—

(4015189) Microbial culture of sputum

1.81

0.98

1.1

2.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.18

0.98

1.4

1.2

—

(4198724) Urine methamphetamine measurement

1.86

0.96

1.6

1.4

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.86

0.96

1.2

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

224

1.39

0.96

1.2

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.89

0.94

1.1

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

109

1.56

0.93

3.1

4.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

134

1.50

0.91

1.6

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

755

1.20

0.91

3.1

3.3

0.32

0.36

iu/ml

0.84

419

(4211845) Urine protein measurement

110

1.55

0.90

4.7

3.7

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

1.60

0.90

1.1

1.2

10.40

9.91

mm/h

0.05

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.75

0.90

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

116

999

1.17

0.88

1.7

1.8

—

(3052851) Hemolysis interference index of Serum or Plasma

658

1.21

0.87

3.1

3.5

2.91

2.20

index

0.24

332

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

129

1.48

0.83

2.3

2.4

—

(40768795) Lymph node Pathology biopsy report

238

0.67

0.83

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.88

0.81

2.0

1.5

—

(3023410) Appearance of Cerebral spinal fluid

250

1.32

0.80

1.8

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

164

0.61

0.80

1.4

1.3

—

(3017704) Immunofixation for Urine

139

1.44

0.79

1.5

1.7

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

1.82

0.79

1.0

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.79

0.0

1.5

—

7.81

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.59

0.78

1.0

1.1

—

(4268621) Lupus anticoagulant assay

234

1.33

0.77

2.5

2.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

1.77

0.76

1.2

1.0

7.42

6.02

mg/g

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.77

0.76

1.5

3.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

253

1.31

0.75

1.2

1.3

6.64

7.54

mmol/l

1.15

221

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

2.09

0.74

1.8

1.1

2.40

4.25

nmol/l

—

(4146454) Self-monitoring of blood glucose

272

1.29

0.73

2.8

2.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

100

1.50

0.72

1.0

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

211

1.33

0.72

1.5

26.24

32.86

0.44

133

(1002224) Polysomnography panel

110

963

1.15

0.71

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.58

0.71

1.2

1.1

—

(4195642) Thrombophilia screening test

309

1.27

0.70

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.92

0.70

1.0

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

276

1.27

0.66

1.8

1.6

50.04

59.71

0.77

177

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

182

1999

0.90

0.66

2.2

2.0

3.41

3.45

ratio

0.19

142

1576

(40758292) HTLV I+II Ab panel - Serum

1.59

0.65

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.59

0.65

1.1

1.4

—

(3006462) Nitrate [Presence] in Urine

103

1.46

0.65

5.2

3.9

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.73

0.64

1.0

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.46

0.61

1.0

1.3

—

0.27

g/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.60

0.0

1.3

—

6.10

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

105

1.43

0.60

1.1

7.1

60.78

69.58

mg/l

—

(3040151) Glucose [Moles/volume] in Capillary blood

254

1.26

0.59

5.1

6.69

7.27

mmol/l

0.71

216

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

327

1.23

0.58

1.0

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

318

1.23

0.58

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.67

0.56

2.0

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.56

2.5

2.3

11.15

18.45

umol/l

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.47

0.54

1.4

1.5

65.92

419.18

nmol/24h

0.53

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.54

0.53

1.2

1.4

—

70.50

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

1.50

0.51

2.8

3.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.50

0.51

1.0

1.3

65.83

69.58

ug/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.50

0.51

1.2

1.3

—

82.00

—

(3016750) Collection duration of Urine

135

0.67

0.51

3.3

2.2

441.00

498.09

min

—

100

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

103

925

1.12

0.50

2.9

3.4

825.12

1872.66

u/ml

0.40

803

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

261

1.23

0.49

1.4

1.7

—

2160.00

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

280

1.22

0.48

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

135

1475

0.91

0.48

2.0

1.8

3.55

3.49

mmol/l

0.24

1049

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

767

1.13

0.47

1.6

1.8

3.34

4.93

mg/l

0.85

570

(1617658) Protocol used for examination of sentinel lymph nodes

222

0.76

0.47

1.0

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

173

1.27

0.46

1.4

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

0.62

0.45

1.0

1.4

63.20

60.32

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

156

1.28

0.45

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.40

0.45

1.3

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

478

1.15

0.45

4.6

4.0

25.18

26.91

mg/l

0.15

338

(3006184) Hemoglobin [Mass/volume] in Capillary blood

591

1.14

0.44

2.1

2.3

130.69

128.04

g/l

0.43

470

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.45

0.44

1.2

1.6

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1807

17852

1.04

0.44

25.6

21.1

13.72

13.68

0.63

1788

17609

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.37

0.44

1.3

1.6

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.41

0.43

1.8

2.5

148.00

175.89

0.29

(3044242) Glucose [Moles/volume] in Arterial blood

151

0.73

0.42

1.5

2.2

8.47

8.95

mmol/l

0.22

151

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

230

1.22

0.42

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.38

0.42

1.0

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.52

0.41

2.4

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(3024316) Viscosity of Plasma

0.00

0.40

0.0

1.6

—

1.78

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.43

0.39

1.4

1.5

3.04

272418.61

nmol/l

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

160

1.25

0.38

1.3

1.7

84.49

102.83

ng/l

0.74

160

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

591

1.12

0.37

1.7

1.3

225.15

221.43

miu/ml

0.03

258

(3023383) Lactate [Moles/volume] in Pleural fluid

1.29

0.36

1.4

1.5

2.20

2.86

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

198

1.21

0.36

1.9

2.2

0.78

1.71

u/field

1.41

108

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.27

0.36

1.1

1.2

—

9.67

—

(3017569) Oxygen content in Arterial blood

146

0.75

0.36

1.9

2.4

15.16

16.14

0.32

146

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

226

1.20

0.35

1.4

259.09

345.69

u/l

0.59

218

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

168

0.77

0.35

1.4

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.43

0.35

3.2

3.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

135

1.26

0.35

1.1

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

135

1.26

0.35

1.6

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

135

1.26

0.35

1.1

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

245

1.19

0.35

2.9

3.4

13.39

12.07

index

0.44

135

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

126

1.27

0.35

1.2

1.1

1.05

1.06

ratio

0.08

105

(3023199) Leukocytes [#/volume] in Pleural fluid

301

1.17

0.35

1.6

1.4

2228.73

1616.27

e6/l

0.38

207

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

163

1.23

0.34

1.8

1.7

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.32

0.33

1.2

2.0

23.08

30.64

1.52

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

100

1.30

0.33

1.0

1.1

—

11.42

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.33

0.32

1.2

1.7

—

0.60

—

(44806420) Estimation of glomerular filtration rate

230

1.18

0.31

3.0

2.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

206

1964

1.05

0.28

4.1

3.9

1.23

mmol/l

0.12

175

1696

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.28

0.28

1.5

1.4

137.45

156.71

pmol/l

0.21

(3012565) Volume of 24 hour Urine

117

0.77

0.27

2.3

2.5

1902.22

1823.40

—

104

(3045788) Cell count panel - Pleural fluid

252

1.15

0.27

1.7

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

374

0.88

0.27

1.5

49.01

61.06

ug/l

1.54

306

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

236

2459

0.96

0.26

3.1

3.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

234

1.16

0.26

1.4

69036.95

129543.17

e6/l

0.34

156

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.19

0.26

3.0

1.4

7.94

8.98

ug/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

278

0.86

0.26

1.9

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

141

1.21

0.26

1.1

—

(3000012) Reticulocyte production index

348

1.12

0.26

1.8

2.2

0.78

0.91

1.07

238

(40768806) Pleura Pathology biopsy report

245

1.14

0.24

1.8

1.6

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

335

3245

1.04

0.24

3.7

3.3

0.76

0.75

ug/l

0.08

241

2121

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.25

0.24

1.9

2.4

57.75

51.78

umol/l

0.30

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

253

0.87

0.22

2.0

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.25

0.22

1.0

—

(40761536) Microorganisms panel - Urine sediment

176

1836

0.96

0.22

4.9

4.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.91

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.2

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.60

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.01

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

2.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3003694) ABO and Rh group [Type] in Blood

638

6262

1.03

0.21

1.5

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

145

0.83

0.21

1.5

1.1

35.74

15.82

u/ml

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.2

—

4782.71

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

117

1.20

0.20

1.4

1.1

—

(40757373) Influenza virus identified in Isolate

1.23

0.20

1.2

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

137

1.17

0.18

1.5

1.4

1.30

1.29

nmol/l

0.02

(1616796) Gas panel - Central venous blood

523

1.07

0.17

3.3

4.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

475

0.92

0.17

5.1

4.0

19.93

33.06

u/ml

2.34

464

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.17

1.1

2.8

4.30

4.81

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.11

0.17

1.1

2.8

11.30

10.01

kpa

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

215

1.12

0.16

1.8

1.5

60.11

56.33

ug/l

0.16

215

(3036071) Salmonella sp Ab [Titer] in Serum

1.10

0.15

1.3

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

255

1.10

0.15

1.7

1.4

61859.17

98342.96

e6/l

0.33

141

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

1.16

0.14

1.0

1.1

—

(3004451) EKG impression Narrative

152

1.12

0.12

1.5

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

291

0.93

0.11

1.4

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

202

1.09

0.10

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

300

0.93

0.10

1.5

—

(40768793) Breast Pathology biopsy report

704

1.04

0.09

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

665

1.04

0.09

2.0

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.08

0.08

1.0

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.12

0.07

1.6

1.5

—

1687199.83

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

313

1.06

0.07

1.4

1.6

—

(3044007) Cell count panel - Peritoneal fluid

1.07

0.07

1.6

1.8

—

(3020650) Glucose [Presence] in Urine

1.07

0.07

1.8

2.0

0.00

0.04

estimate

—

(3005033) Fetal Nuchal fold Thickness US

285

0.95

0.06

1.4

1.5

1.23

1.29

0.33

197

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

105

0.86

0.06

2.0

3.6

0.89

1.29

—

105

(3027456) Digoxin [Moles/volume] in Serum or Plasma

545

1.03

0.05

4.0

3.5

0.83

0.82

nmol/l

0.13

438

(3000034) Microalbumin [Mass/volume] in Urine

189

1.06

0.04

3.5

3.0

27.74

28.33

mg/l

0.01

140

(40765096) Chromosome analysis panel by Banding

1.10

0.04

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

1.06

0.04

1.4

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

352

0.97

0.04

1.4

1.5

0.98

1.23

ratio

1.75

221

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

352

0.97

0.04

1.4

1.5

0.92

0.98

ratio

0.66

221

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

352

0.97

0.04

1.4

1.5

1.05

1.16

ratio

0.51

221

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

300

1.03

0.03

1.9

1.6

—

(3012501) Base excess in Blood by calculation

471

0.98

0.03

4.2

4.7

2.21

2.70

mmol/l

0.59

329

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

192

1.04

0.02

1.3

1.7

—

(44813793) Dust mix specific IgE antibody measurement

153

1.05

0.01

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

627

0.99

0.01

1.7

1.6

802.41

1000.22

mu/l

1.49

510

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

346

0.98

0.00

1.4

1.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

115

1.04

0.00

11.7

16.1

733.42

810.67

nmol/l

0.29

110

(40768800) Prostate Pathology biopsy report

345

0.99

0.00

1.3

1.2

—

(3012441) Differential panel - Pleural fluid

249

1.00

0.00

1.6

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

146

1.03

0.00

1.5

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

424

0.99

0.00

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

138

1.01

0.00

3.6

2.7

31.78

41.97

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

142

0.99

0.00

1.5

1.6

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

107

1.03

0.00

2.2

2.3

119.64

155.04

0.57

101

(3017400) Magnesium [Moles/volume] in Urine

0.00

0.0

1.0

—

3.13

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3024263) Appearance of Synovial fluid

120

1.00

-0.00

1.4

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

299.40

—

(4038314) Semen analysis, post vasectomy

0.00

-0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.94

-0.00

2.6

1.5

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

179.80

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.99

-0.00

2.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

510

1.00

-0.00

2.8

2.4

296.12

109.92

ug/min

0.76

308

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

172.43

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.39

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

1.44

—

(3007733) Chloride [Moles/volume] in Urine

0.00

-0.00

0.0

1.4

—

59.80

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

0.08

—

Mortality – FinRegistry

↥

Association

Association between endpoint TONGUEABNORMALITY and mortality.

Females

Parameter	HR [95% CI]	p-value
TONGUEABNORMALITY	1.01 [0.92, 1.11]	0.844
Birth year	0.995 [0.99, 1.0]	0.198

During the follow-up period (1.1.1998 — 31.12.2019), 1280 out of 7837 females with TONGUEABNORMALITY died.

Males

Parameter	HR [95% CI]	p-value
TONGUEABNORMALITY	1.287 [1.14, 1.45]	< 0.001
Birth year	0.981 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 860 out of 3953 males with TONGUEABNORMALITY died.

Mortality risk

Mortality risk for people of age

years, who have TONGUEABNORMALITY.

N-year risk	Females	Males
1	0.09%	0.154%
5	0.613%	1.159%
10	1.581%	2.976%
15	2.907%	5.429%
20	5.079%	9.175%

Relationships between endpoints

↥

Index endpoint: TONGUEABNORMALITY – Tongue abnormality

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Tongue abnormality

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints